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During the last decade, cholinergic signaling via acetylcholine and its receptors has emerged as an 
important regulator of immunity. Acetylcholine binds to and signals through two types of receptors; 
nicotinic and muscarinic receptors. Studies have shown that signaling through nicotinic receptors, 
particularly the α7 subtype on macrophages has potent anti-inflammatory effects. However, the role 
for muscarinic receptor has not yet been conclusively characterized. In this study, we demonstrate 
that M3 muscarinic receptor subtype is required for optimal protective immunity to two pathogens; 
the nematode Nippostrongylus brasiliensis and the bacterium Salmonella enterica sp. Tyhpimurium. M3R 
deficient mice (M3R-/-) were susceptible to infection with N.brasiliensis with decreased production of 
the protective cytokine IL-13. Furthermore, stimulation of lymphocytes with muscarinic agonists 
enhanced TH2 cytokine production in an M3R dependent manner. We identified CD4 T cells as the 
main immune cell type affected in M3R-/- mice with protection elicited by adoptive transfer of 
antigen experienced CD4 T cells completely abrogated in the absence of M3R. We also found that 
M3R was required for regulating a TH1 biased immune response induced by S.typhimurium and M3R
-/- 
mice were more susceptible having up to 20 fold higher bacterial burden in the spleen at day 27. 
Similarly, CD4 T cells from M3R-/- mice had reduced production of IFN-γ and expression of its 
upstream transcription factor Tbet. Following infection with both pathogens, a lower proportion of 
CD4 T cells were activated in M3R-/- mice and also had reduced expression of the T cell 
costimulatory receptor CD28, hence providing a potential mechanism for M3R mediated immune 
regulation. Our data provides the first conclusive evidence of a role for the muscarinic receptor 
subtype M3 in enhancing T helper type 1 and 2 immune responses following infection. Unlike, 
nicotinic receptors which dampen immune responses, we find that muscarinic receptors are pro-
inflammatory and function to enhance immune responses, influencing the activity of CD4 T cells 















































The immune system is an important physiological response mechanism that protects against entry of 
foreign microorganisms or particles that may harm the body. At the same time, the immune system 
also has to recognize and maintain tolerance to self-antigens and commensal microorganisms as an 
inappropriate response towards these can be destructive to the host (Janeway 1992; Van Parijs and 
Abbas 1998; Lathrop, Bloom et al. 2011). The immune system has thus developed two distinct arms, 
the innate and adaptive systems, to recognize and control pathogenic insult as well as to develop 
long term memory immunity which can protect against future infections by the same pathogen 
(Murphy, Travers et al. 2012). 
 
1.1. Innate and Adaptive Immunity: 
The innate immune system is the rapid response arm of the immune system and is activated within 
hours of a pathogenic infection (Fearon and Locksley 1996). A number of cell types such as 
macrophages, neutrophils, dendritic cells, natural killer cells, eosinophils and mast cells are 
associated with innate immunity (Janeway and Medzhitov 2002). A common feature of these cells is 
their ability to detect a broad spectrum of pathogens using pattern recognition receptors on their cell 
surface such as the Toll-like receptors (TLR) (Medzhitov and Janeway 1997). Effector mechanisms 
for innate immune cells include phagocytosis of pathogens into specialized structures called 
phagosomes where they can be destroyed and in the case of Antigen Presenting Cells (APCs) display 
the pathogenic antigens for activating the adaptive immune system. Innate immune cells also contain 

















destroy extracellular pathogens and infected cells. Innate immunity includes non-cellular 
components such as the complement system, a number of plasma proteins that can bind to 
pathogens and assist in their uptake and destruction (Beutler 2004). An important feature of the 
innate immune system is its ability to activate the adaptive immune system which then ensures 
complete elimination of the pathogen as well as development of immune memory for the specific 
pathogen in case of a re-infection (Medzhitov and Janeway 1997). 
 
The adaptive immune response comprises mainly of T and B lymphocytes that develop later in an 
infection but are highly specific for the pathogen. T and B lymphocytes express a broad repertoire of 
T cell (TCR) and B cell (BCR) receptors respectively which theoretically span the entire antigen 
spectrum of foreign organisms. The specificity of the adaptive immune response arises from 
activation and proliferation of only those clones of T and B lymphocytes that express receptors 
complementary to pathogen antigens displayed by APCs. T lymphocytes are further classified into 
CD4 Helper T cells and CD8 Cytotoxic T cells (Murphy, Travers et al. 2012). CD4 T cells produce 
immunomodulatory proteins called cytokines that can assist B cell development into antibody-
producing cells and to activate phagocytes such as macrophages to enhance intracellular pathogen 
killing (Adams and Hamilton 1984; Parker 1993). CD8 T cells can directly kill other host cells 
infected by viruses or intracellular pathogens using a variety of toxic enzymes such as perforins 
(Sallusto, Geginat et al. 2004). B lymphocytes upon activation develop into plasma cells which 
secrete antibodies that bind specifically to pathogens and other foreign antigens. Antibody bound 
foreign particles undergo enhanced uptake by macrophages and are thus more readily eliminated 


















The immune system is an exquisitely controlled system, with the innate and adaptive immune system 
working together to limit spread of pathogens and to develop memory immunity that responds 
more rapidly when the pathogen is encountered a second time. However, uncontrolled inflammation 
targeted at the pathogen can also damage the host’s own tissue and therefore must be tightly 
regulated. The body also has to control aberrant immune responses to self-antigens, benign 
environmental antigens and beneficial commensal micro-organisms. The immune system has thus 
developed a mechanism of regulating the immune system comprising of regulatory T cells 
(Josefowicz, Lu et al. 2012). Regulatory T cells are specialized CD4 T cells that express the 
transcription factor Forkhead box P3 (FoxP3) and can limit inflammatory responses from other 
immune cells (Fontenot, Gavin et al. 2003; Khattri, Cox et al. 2003; Fontenot, Rasmussen et al. 
2005). Regulatory CD4 T cells employ cell surface receptors such as the T cell inhibitory receptor 
CTLA-4 (Read, Malmstrom et al. 2000; Read, Greenwald et al. 2006) and secrete cytokines such as 
IL-10 and TGF-β in order to achieve immune suppression (Li, Wan et al. 2007; Rubtsov, Rasmussen 
et al. 2008). Other mechanisms also exist for controlling the immune system including apoptosis of 
activated immune cells and secretion of steroids such as glucocorticoids (Krammer 2000; De 
Bosscher and Haegeman 2009) 
 
1.2. Classes of Immune response : TH1 Versus TH2 
CD4 T lymphocytes are central regulators of the adaptive immune system and ensure that an 
appropriate immune response is generated that facilitates clearance of pathogens but at the same 
time limits tissue damage. The first attempt at classifying CD4 Helper T cells into distinct subsets 
was proposed by Mosmann and Coffman as the T Helper type 1 (TH1) and T Helper type 2 (TH2) 
based on their cytokine profile (Mosmann and Coffman 1989). The TH1 response is pro-

















protozoan and viral infections. Cytokines that are characteristic of a TH1 response include IFN-γ, 
TNF-α and IL-12 can activate macrophages to promote intracellular killing as well as to act in a 
positive feedback loop to increase pro-innflammatory cytokine production (Szabo, Sullivan et al. 
2003).  
TH2 responses on the other hand are characterized by the cytokines IL-4, IL-5 and IL-13 and is 
associated with resolving helminth infections and conversely causing allergic reactions (Mosmann 
and Sad 1996). TH2 unlike TH1 responses are not inflammatory and may have evolved to prevent 
tissue destruction during chronic helminth infections. Effector mechanisms induced by TH2 
cytokines are also geared towards expulsion of helminth parasites and include increased smooth 
muscle contractility, mucus production from goblet cells, epithelial cell turnover and recruitment of 
eosinophils (Anthony, Rutitzky et al. 2007). This TH2 induced immunopathology is beneficial during 
helminth infection however can also be detrimental in the case of allergic reactions (Yazdanbakhsh, 
van den Biggelaar et al. 2001).  The TH1/TH2 paradigm has more recently been extended to include 
other distinct responses such as TH17, another pro-inflammatory response that develops during 
fungal infections and regulatory T cells (Treg), a subset that actively downregulates inflammation and 
CD4 T cell activity (Mosmann and Sad 1996; Korn, Bettelli et al. 2009). 
Other classes of immune responses such as the T helper 17 (TH17) and Regulatory T cell have since 
been discovered to expand our understanding of the distinct classes of immune response. 
 
2. Acetylcholine and the immune system:  
Acetylcholine is the first neurotransmitter discovered in humans and is responsible for nerve 
impulse transmission across synapses in the central nervous system. Acetylcholine synthesis, 
however, has also been identified in a number of non-neuronal cellular sources indicating that 

















al. 1998; Kawashima and Fujii 2004). It is also produced by a variety of lower organisms without a 
nervous system such as plants, bacteria and protists, suggesting that this molecule is an ancient 
signaling molecule which has been retained by evolution in higher organisms (Wess, Eglen et al. 
2007).  
 
Acetylcholine in humans has diverse roles depending on its cellular source as well as its target cell.  
Neuronal sources of acetylcholine are predominantly responsible for maintaining nerve impulse 
transmission across synaptic junctions where acetylcholine produced by the pre-synaptic neuron 
binds to an appropriate receptor on the post-synaptic neuron (Caulfield 1993; Dajas-Bailador and 
Wonnacott 2004). In addition, acetylcholine acts as an important signaling molecule in 
neuromuscular junctions where it stimulates muscular contraction upon binding specific receptors 
on smooth muscles (Caulfield 1993). Non-neuronal cellular sources of acetylcholine also possess the 
enzyme necessary to synthesize acetylcholine as well as the enzymes for its transport, storage and 
degradation. These sources include skin keratinocytes, bone forming osteoclasts and importantly 
components of the immune system such as CD4 T cells, B cells, macrophages and dendritic cells 
(Fujii, Takada-Takatori et al. 2008; Kawashima and Fujii 2008).  
 
Over the past decade, a number of studies have shown an emerging role for acetylcholine in 
immunity. Tracey et al. have, in a series of papers, shown that acetylcholine secretion following vagus 
nerve stimulation, particularly from a subset of activated CD4 T cells in the spleen, can suppress 
pro-inflammatory immune responses in a murine model of endotoxaemia (Borovikova, Ivanova et 
al. 2000; Wang, Yu et al. 2003; Rosas-Ballina, Olofsson et al. 2011). However, very little is known 
about the role of acetylcholine and its associated molecular machinery in regulating host immune cell 

















2.1. Acetylcholine receptors: 
Acetylcholine acts as a signaling molecule by binding specifically to receptors on the surface of target 
cells. In mammalian systems, acetylcholine binds to and signals via two distinct families of receptors 
known as the nicotinic and muscarinic receptors (Felder 1995). 
 
Fig 1. Different mechanisms of action of two distinct acetylcholine receptors; nicotinic receptor, a 
ligand gate ion channel and muscarinic receptor, a GPCR. 
 
2.1.1. Nicotinic receptor:  
Nicotinic receptors are pentameric cell surface receptors, comprising of one (homo-meric) or more 
(hetero-meric) types of subunits, which upon binding acetylcholine undergo a rapid conformational 
change to allow influx of Na+ ions into and efflux of K+ out of target cells. This mainly occurs at the 
synapse between two neurons and is the classical method of propagating nerve impulses. Some 

















genes and enzymes.  The prototypical agonist for nicotinic receptors is nicotine from which the 
receptor derives its name (Brejc, van Dijk et al. 2001).Nicotinic receptors are mainly found in the 
synapses of neurons or at the neuromuscular junction. Immune cells such as macrophages and CD4 
T cells also express functional nicotinic receptors (Toyabe, Iiai et al. 1997; Wang, Yu et al. 2003). 
 
2.1.2 . Muscarinic receptor: 
Muscarinic receptors are classical G-protein coupled receptors (GPCRs) that also bind acetylcholine 
to initiate a downstream signaling cascade resulting in influx of ions into the cell, which unlike with 
the nicotinic receptor, is a slower process and involves a number of intermediate secondary 
messengers. The initiation of signaling proceeds via a G protein that is bound to a GPCR, and can 
further activate a number of important signaling molecules such as kinases (Caulfield 1993; Felder 
1995). 
 
Muscarinic receptors are divided into 5 subtypes namely the M1-M5 and can be placed in two 
distinct groups depending on the associated G protein and secondary messengers utilized. These 
receptors have also been highly conserved in mammalian species as analysis of amino acid sequences 
shows a high degree of similarity (over 90% in most cases). The M1, M3 and M5 receptors are 
activating in nature and bound to the G protein Gq protein which upon stimulation causes an 
increase in the secondary messenger inositol triphosphate (IP3). In contrast, the M2 and M4 
receptor are inhibitory, associate with the Gi protein and upon stimulation results in a decrease in 
cyclic AMP (cAMP), another secondary messenger.  (Caulfield and Birdsall 1998; Abrams, 
Andersson et al. 2006).  
Muscarinic receptors are widely expressed both in the central nervous system and periphery where 

















receptors are involved in motor control, temperature and cardiovascular regulation. In the periphery, 
muscarinic receptors regulate processes such as cardiac rate, smooth muscle contraction and 
glandular secretions (saliva and insulin) (Wess 1993; Wess, Eglen et al. 2007).  
 
2.2. Acetylcholine synthesis and transport enzymes 
Acetylcholine is a 146 KDa molecule synthesized from the abundant cellular precursors acetyl-CoA 
and choline in a reaction that is catalyzed by the enzyme Choline acetyltransferase (ChAT) (Oda 
1999). This reaction occurs primarily in the pre-synaptic neuron where the newly synthesized 
acetylcholine is packaged into vesicles and transported by the Vesicular acetylcholine transporter 
(VAChT) (Arvidsson, Riedl et al. 1997). However, neuronal cells are not the only source of 
acetylcholine in the body. A number of non-neuronal cell types have also been identified which are 
capable of synthesizing and secreting acetylcholine on the basis of expression of the ChAT enzyme 
which acts as a useful marker for non-neuronal sources as acetylcholine is labile and prone to 
degradation (Wessler, Kilbinger et al. 2001). Therefore a number of molecular techniques such as 
RT-PCR, western blotting and GFP tagged ChAT have been used so far to identify cell types 
capable of producing acetylcholine (Rathenberg, Gartner et al. 2002). Some studies have even been 
able to detect measurable amounts of acetylcholine using High Pressure Liquid Chromatography 
(HPLC) from non-neuronal cells as a further proof of its synthesis by non-neuronal cells 
(Klapproth, Reinheimer et al. 1997; Fujii, Tajima et al. 1999). Cells such as bone osteoclasts, skin 
keratinocytes, and immune cells such as CD4 T cells, dendritic cells have all been shown to express 
ChAT (Wessler, Kilbinger et al. 2001). Interestingly, dendritic cells up-regulate ChAT mRNA 
expression levels after stimulation implying that changes in acetylcholine production may be 


















2.3. Degradation of acetylcholine (Acetylcholinesterase) 
Acetylcholine is a potent signaling molecule and needs to be removed rapidly after its release to 
prevent continuous stimulation of nerves and muscles. The hydrolysis of ACh is catalyzed by 
Acetylcholinesterase (AChE), an enzyme that is found mainly in post-synaptic neurons (Massoulie 
and Bon 1982) and red blood cells (Steck 1974) but can also be produced by immune cells such as 
macrophages and T cells (Szelenyi, Bartha et al. 1982; Klegeris, Budd et al. 1994). In neurons, AChE 
breaks down acetylcholine into acetate and choline, which is recycled back to the pre-synaptic 
neuron to be re-synthesized. In immune cells, it has been postulated that acetylcholinesterase is 
required to lower acetylcholine in the surrounding milieu hence reduce its anti-inflammatory effects 
(Nizri, Hamra-Amitay et al. 2006). This principle was conclusively demonstrated when a microRNA 
(miRNA) that targets AChE for degradation was identified (Shaked, Meerson et al. 2009). In 
macrophages, AChE levels are tightly regulated by the microRNA miR-132 which targets AChE 
transcripts for degradation with subsequent increase in the acetylcholine levels. In activated 
macrophages, there is a significant increase in miR-132 as a regulatory measure in order to limit pro-
inflammatory cytokine production via acetylcholine. Conversely, when AChE transcripts are 
modified to render them insensitive to miR-132, there is an increase in pro-inflammatory cytokines 
IL-1β and IL-6 as a result of decreased acetylcholine availability. This further demonstrates that 
acetylcholine is an important regulator of the immune system and acts as an anti-inflammatory signal 
at least for macrophages (Shaked, Meerson et al. 2009). The body has thus developed various 
mechanisms to regulate the availability of acetylcholine by regulating enzymes involved in its 
synthesis and degradation so as to achieve the desired level of inflammation. Since the nervous 
system is the major producer of acetylcholine, it also raises the possibility that it can control the 


















Table 1: Functions of different components of the cholinergic system in regulating immunity 
Cholinergic 
component 













































- AChE inhibitors 
reduce IL-1β in brain 














Binds acetylcholine to 
reduce TNF-α 
production 
(Wang, Yu et al. 2003) 
M1 muscarinic CD8 T cell - Development of 
cytolytic T cell 
responses in vitro. No 
defect in M1R-/- CD8 
T cells in vivo.  
(Zimring, Kapp et al. 
2005; Vezys, Masopust 
et al. 2007) 




- Stimulation induces 
Ca2+ influx and c-fos 
gene expression 





Human T cell 
line (Jurkat) 
- Enhance IL-2 
production blocked by 
atropine and M3 
receptor specific 
antagonist 4-DAMP 



















2.4. The Cholinergic Anti-Inflammatory Pathway (CAP) 
Historically, the immune system was viewed as an autonomous physiological process that operated 
outside the influence of the central nervous system. However, this dogma was challenged when a 
study by Tracey et al published 10 years ago showed that electrical stimulation of the vagus nerve can 
significantly inhibit pro-inflammatory cytokine production and improve survival during LPS induced 
endotoxemia in a murine model (Borovikova, Ivanova et al. 2000). This led to a paradigm shift in 
which the immune system was highly influenced by the nervous system was termed Cholinergic 
Anti-inflammatory Pathway (CAP). Further studies by the Tracey lab demonstrated that vagus nerve 
stimulation affected macrophages in the spleen which produced lower amounts of TNF-, the 
cytokine that drives pathophysiology of LPS induced toxic shock. The receptor that regulates this 
effect is the alpha7 subunit of the nicotinic receptor (7nAChR) on macrophages as vagal 
stimulation in 7nAChR deficient mice did not result in TNF-α suppression (Wang, Yu et al. 2003).  
 
The actual source of acetylcholine remained ambiguous as no acetylcholine-secreting cholinergic 
nerves have been found in the spleen which could serve as a link between the vagus nerve and 
macrophages (Rosas-Ballina, Ochani et al. 2008). However, this discrepancy was resolved by a study 
which showed that the source of acetylcholine is a certain population of activated (CD44hiCD62Llo) 
CD4 T cells in the spleen that expresses choline acetyltransferase (ChAT).The vagus nerve endings 
which innervate the T cell zones in the spleen are adrenergic, producing the neurotransmitter 
noradrenalin which can directly stimulate the ChAT positive CD4 T cell subpopulation to increase 
acetylcholine secretion. When this ChAT positive population was transferred into nude mice that 

















Ballina, Olofsson et al. 2011). This was the first clear evidence of a non-neuronal source of 
acetylcholine modulating the immune system (Trakhtenberg and Goldberg 2011). 
   
 
Fig 2: Regulation of cytokine production by the Cholinergic Anti-Inflammatory Pathway (CAP). 
Adapted from Andersson and Tracey, Journal of Experimental Medicine (Andersson and Tracey 
2012) 
Regulation of inflammation by the cholinergic anti-inflammatory pathway has now been shown for 
many other disease models such as collagen induced arthritis (Zhang, Han et al. 2008), sepsis 
(Huston, Gallowitsch-Puerta et al. 2007), ischemia-reperfusion injury (Bernik, Friedman et al. 2002) 
and DSS induced colitis (Ghia, Blennerhassett et al. 2006) indicating that CAP via the vagus nerve 
may be one of the main ways by which the body limits excessive inflammation. The existence of 
CAP also raises the possibility of pharmacological interventions targeting this pathway. Since the 
nicotinic receptor plays a central role in CAP, exogenous administration of nicotine may control the 

















ulcerative colitis, a painful condition caused by excessive inflammation in the gut, were treated with 
nicotine. A significantly higher proportion of patients had complete remission after nicotine 
treatment suggesting that CAP can be manipulated pharmacologically to reduce inflammation in 
certain diseases (Sandborn, Tremaine et al. 1997; Guslandi 1999). 
 
3. M3 muscarinic receptor: 
 
3.1. Structure and classical signal transduction pathway. 
Muscarinic M3 receptor (M3R) is a G-protein coupled receptor with the characteristic 7-
transmembrane region that is structurally similar to the classic GPCR rhodopsin. Human M3 
receptor is made up of 590 aa and is highly similar to murine M3 receptor (589 aa) with a sequence 
similarity of 92% (pairwise sequence alignment using LALIGN) as well as across other species such 
as pig and rat (Caulfield and Birdsall 1998) implying that the M3R has been highly conserved and is 
likely to exhibit similar functions across species. 
 
The N-terminal end of the M3 receptor is extracellular and is heavily glycosylated whereas the C-
terminal is located intracellularly and associates with the Gq/11 family of G-proteins which are 
responsible for initiating the downstream signaling cascade (Caulfield 1993). The M3R, like all 
muscarinic receptors, is a cationic amine receptor which binds its ligand acetylcholine using an 
Aspartic residue in the third extracellular loop. This binding initiates a downstream signaling cascade 
that starts with phosphorylation of the  subunit of the Gq/11 , which detaches from the C-terminal 
end of the M3R to activate Phospholipase C (PLC) through a series of kinases (Exton 1996). PLC 

















act as secondary messengers. This results in the release of Ca2+ ions from intracellular sources and 
subsequent increase in Ca2+ ion concentration, which is responsible for mediating the functional 
effects of M3R such as smooth muscle contraction and glandular secretion (Lanzafame, 
Christopoulos et al. 2003).  
 
A major problem with studying muscarinic receptors is the structural similarity particularly at the 
active site of the 5 subtypes. However, the crystal structure of the M3 receptor has recently been 
solved making it easier for rational design of subtype specific ligands (Kruse, Hu et al. 2012).  
 
3.2. Characterization of M3 muscarinic receptor knockout mouse. 
Transgenic mice lacking each of the 5 muscarinic receptor subtypes have been generated and are 
reproductively viable thus making them a valuable tool in dissecting the role of individual receptor 
subtypes (Hamilton, Loose et al. 1997; Gomeza, Shannon et al. 1999; Gomeza, Zhang et al. 1999; 
Yamada, Lamping et al. 2001; Yamada, Miyakawa et al. 2001). All 5 knockout mouse strains have 
been systematically tested for wide range of physiological defects providing subtype specific roles for 
the muscarinic receptor. These insights have allowed pharmaceutical companies to design more 
subtype selective and ultimately more clinically relevant drugs (Wess, Eglen et al. 2007). Some 
examples of physiological functions identified include inhibition of β-amyloid particle deposition 
(M1), regulation of heart rate (M2), smooth muscle contractility (M3) and decrease in cocaine 
addiction (M5). 
 
The M3 receptor knockout mice (M3R-/-) was first reported in a study that characterized functional 
defects in peripheral autonomic organs in this mutant mouse strain. The M3 receptor gene (Chrm3 in 

















confirmed using western blotting to show complete absence of M3 receptors in the brain of 
homozygous M3R-/- mice (Matsui, Motomura et al. 2000). This mouse strain has thus become a 
valuable tool in dissecting various functional roles of the M3R (Wess, Eglen et al. 2007). 
 
3.3. Roles of non-neuronal M3 receptor. 
The muscarinic M3 receptor is highly expressed on non-neuronal cells in the periphery (outside of 
the nervous system) particularly on smooth muscle cells (Eglen, Reddy et al. 1994; Eglen, Hegde et 
al. 1996); exocrine glands such as pancreas (Gautam, Han et al. 2006), salivary glands (Gautam, 
Heard et al. 2004); keratinocytes (Ndoye, Buchli et al. 1998); tumour cells (Oppitz, Busch et al. 2008; 
Raufman, Samimi et al. 2008) and immune cells such as CD4 T cells, macrophages, and dendritic 
cells (Fujii, Watanabe et al. 2003; Kawashima, Yoshikawa et al. 2007). Due to this widespread 
expression, the M3R has been associated with a wide range of physiological roles, some of which 
have been experimentally verified and other hypothetical roles with some experimental evidence. 
 
3.3.1. Smooth muscle contraction: 
The parasympathetic nervous system controls smooth muscle contraction by using acetylcholine to 
stimulate muscarinic receptors  resulting in a contractile response (Nadel and Barnes 1984). M3 
muscarinic receptor has been identified as the major regulator of this process using M3R specific 
antagonists as well as M3R deficient mouse strains (Loenders, Rampart et al. 1992; Matsui, 
Motomura et al. 2000). This discovery was important pharmacologically, as a number of specific M3 
inhibitors were developed to target this contractile response which is an important pathological 

















disorders (Hegde and Eglen 1999) resulting in approved drugs such as Spiriva® (Tiotropium 
bromide) and Darifenacin®.  
 
Smooth muscle contraction is initiated by acetylcholine binding to a M3 muscarinic receptor which 
activates a signaling cascade which results in release of Ca2+ ions from intracellular stores and 
extracellular entry. This increase in Ca2+ in the cytosol facilitates contraction through major 
structural proteins such as actin and myosin (Ebashi and Ebashi 1964; Bremel 1974). 
 
3.3.2.  Secretion from exocrine and endocrine glands: 
M3 receptor expression has been observed in a number of peripheral organs, particularly on 
secretory cells of certain exocrine and endocrine glands where its function has been well 
characterized. Exocrine glands such as the salivary gland are responsive to acetylcholine produced by 
parasympathetic neurons resulting in secretion of saliva by acinar cells (Baum 1993). Exocytosis of 
saliva from acinar cells is initiated by an increase in intracellular Ca2+, a process dependent on 
muscarinic receptor stimulation similar to that observed in smooth muscle cells (Turner and Sugiya 
2002). In vivo, M1 and M3 muscarinic receptors were identified as the main subtypes regulating this 
process using muscarinic receptor deficient mice (Gautam, Heard et al. 2004). 
 
Control of endocrine secretion, most notably insulin secretion, by the M3 muscarinic receptor has 
been extensively studied due to the potential therapeutic application in obesity and diabetes (Gilon 
and Henquin 2001). Insulin is produced and secreted by β-pancreatic cells found in the islets of 
Langerhans in response to increased blood glucose levels after feeding. Acetylcholine acts in synergy 
with glucose to increase intracellular Ca2+ which drives the exocytosis of insulin (Garcia, Hermans et 

















as demonstrated using β-cell specific M3 receptor knockout mice (Gautam, Han et al. 2006). 
Interestingly, in models of obesity and obesity-induced insulin tolerance, M3 receptor deficient mice 
have a more favorable outcome suggesting that, in these models at least, antagonizing M3 receptor 
function may be beneficial (Gautam, Gavrilova et al. 2006). Another interesting observation is that 
in mice, unlike humans, the pancreatic islets are well innervated with parasympathetic neurons which 
act as a source of acetylcholine. However in humans, alpha cells which also reside in the islets of 
Langerhans, are the main source of acetylcholine that prime nearby β-cells to secrete insulin 
(Rodriguez-Diaz, Dando et al. 2011). 
 
3.3.3.  Proliferation of tumor cells: 
Expression of the M3 muscarinic receptor has been identified in a number of carcinoma cell lines 
such colon cancer, prostate carcinoma, gastric cancer as well as primary cancer cells (Frucht, Jensen 
et al. 1999; Kodaira, Kajimura et al. 1999). A characteristic feature of tumor cells is their ability to 
proliferate rapidly and muscarinic receptors particularly the subtypes M1 and M3 were associated 
with modulating growth of cells in vitro (Brown, Sah et al. 1997). Colon cancer cell lines exhibit 
different levels of M3 expression, with high expressing cell lines showing Ca2+ mobilization and 
increased proliferation when stimulated with muscarinic agonists which could be blocked by specific 
antagonists of M3 receptors (Frucht, Jensen et al. 1999). Acetylcholine acts as the autocrine growth 
signal via M3R at least for one of the colon cancer cell line (H508) which can secrete acetylcholine 
and this increased proliferation can be inhibited by atropine and a specific M3R antagonist p-sila-
difenidol (Cheng, Samimi et al. 2008). Interestingly, in a murine model of colon neoplasia induced by 
azoxymethane, mice lacking M3R (M3R-/-) had a significantly reduced number and size of tumors 
suggesting that M3 receptors are also important for regulating cellular proliferation in vivo (Raufman, 

















lung carcinoma model both in vivo and in vitro where administration of Darifenacin, a M3R specific 
antagonist, inhibited tumor growth (Song, Sekhon et al. 2007). The growth stimulating effect of 
M3R is likely due to its effect  on pro-proliferative signaling proteins Mitogen Activated Protein 
Kinase (MAPK) and Epidermal Growth Factor (EGF) (Cheng and Raufman 2005; Song, Sekhon et 
al. 2007). 
 
3.3.4. Regulation of Apoptosis: 
Apoptosis is a term used to describe programmed cell death, a series of controlled processes by 
which a target cell undergoes cell death and is consequently removed without eliciting inflammatory 
responses (Elmore 2007). This process is commonly observed during removal of infected cells, auto-
reactive thymocytes in the thymus, and cells with damaged DNA caused by UV radiation 
(Zimmermann and Green 2001). Muscarinic receptors have been shown to be protective against 
chemical induced apoptosis in a number of cell lines in vitro by using non-specific muscarinic 
agonists such as oxotremorine-M (Lindenboim, Pinkas-Kramarski et al. 1995; De Sarno, Shestopal 
et al. 2003). Muscarinic receptor subtypes M1, M3 and M5 that couple to the Gq/11 pathway 
significantly attenuated apoptosis when transfected into a Chinese Hamster Ovary (CHO) cell line 
where as M2 and M4 which couple to a different G protein do not. The C-terminal tail of M3 
muscarinic receptor was determined as the main regulator of the anti-apoptotic effect, and this effect 
is independent of classical muscarinic activated pathways such as Phospholipase C, Janus Kinase 
(JNK) and extracellular regulated kinase (ERK) activation (Budd, McDonald et al. 2003). 
Stabilization of the anti-apoptotic protein Bcl-2 was identified as the potential anti-apoptosis 
mechanism as M3 receptor activation inhibits Bcl-2 degradation (Budd, Spragg et al. 2004). 


















3.4. M3 receptor on immune cells. 
The M3 receptor as highlighted in the previous section plays an important role in diverse cell types, 
in most cases by initiating a signaling cascade which results in influx of intracellular calcium, a 
secondary messenger. However, its role on immune cells remains elusive. Before the discovery of 
the cholinergic anti-inflammatory pathway (CAP), Kawashima and colleagues published a number of 
studies characterizing the expression of cholinergic components particularly muscarinic and nicotinic 
receptors on immune cell types (Kawashima and Fujii 2004). After the prominent immunological 
role demonstrated for nicotinic receptor in CAP (Wang, Yu et al. 2003), it was hypothesized that a 
potential role exists for muscarinic receptors which also feature prominently on immune cells.  
 
M3R, together with other muscarinic subtypes, is expressed by a number of human leukemic T cell 
lines such as Jurkat, CEM and MOLT-3 as well as in peripheral blood mononuclear cells (PBMCs) 
and alveolar macrophages (Kaneda, Kitamura et al. 1993; Hellstrom-Lindahl and Nordberg 1996; 
Sato, Fujii et al. 1999; Koarai, Traves et al. 2012). Stimulation of CEM T cells with oxotremorine-M 
induced calcium influx which could be inhibited by 4-DAMP, an M3 specific inhibitor indicating 
that the M3 receptor is functional on these cells (Fujii and Kawashima 2000; Fujii and Kawashima 
2000). The M3 receptor has also been identified in murine mononuclear leukocytes, dendritic cells 
and macrophages (Kawashima, Yoshikawa et al. 2007). Therefore, there is enough evidence to show 
conclusively that M3 receptors exist on immune cells. However, few studies have tried to identify an 
immune related function for this receptor. In vitro, polarization of naïve CD4 T cells to TH1, TH2 or 
TH17 using an appropriate cocktail of cytokines results in changes in expression levels of muscarinic 
and nicotinic receptors. Interestingly, M3R is significantly down-regulated at the mRNA and protein 


















M3 receptors have not been investigated for potential immune cell function in vivo but muscarinic 
receptors in general and certain subtypes have been studied. Continuous administration of low-dose 
atropine, a muscarinic antagonist, by osmotic pumps results in a significant attenuation of 
inflammation induced by turpentine. It also reduced antigen specific T cell proliferation and number 
of antibody producing cells after immunization with sheep red blood cell (SRBC), a commonly used 
antigen. The opposite effect was observed when oxotremorine-M was administered, with increased 
T cell proliferation SRBC antibody production indicating that muscarinic receptors, unlike nicotinic 
receptors, may be pro-inflammatory (Razani-Boroujerdi, Behl et al. 2008). M1 but not M3 receptors 
were also found to be important for generation of functional cytotoxic T lymphocytes (CTL) from 
CD8 T cells in vitro (Zimring, Kapp et al. 2005). In vivo, however, M1R is not required for optimal 
CD8 responses as M1R specific knockout mice are not susceptible to viral infection (Vezys, 
Masopust et al. 2007). Antibody responses are also affected by certain muscarinic receptor subtypes. 
M1R/M5R double knockout mice produce significantly lower total and antigen specific IgG1 but 
not IgM after immunization with ovalbumin. OVA restimulated splenocytes from these cells also 
secrete less IFN-γ and IL-6 indicating a role for M1 and/or M5 receptors in cytokine production 





















4. Murine infectious disease models: 
Murine models of infectious diseases are an important tool for studying cellular mechanism of 
immune responses to various human (and related) pathogens and to facilitate translation of these 
findings to human studies. Studying immune responses are particularly useful during early stage 
vaccine development as well as to identify correlates of protection such as cytokines and other 
cytotoxic molecules. Murine models for all major classes of pathogens such as bacteria, viruses, 
protists, fungi, and helminths have been developed and together with genetically modified mouse 
strains provide a powerful platform to study a broad range of host-pathogen interactions. Below, the 
two pathogens used in this study will be reviewed. 
Fig 3. Known and hypothesized non-neuronal roles of M3 Muscarinic receptor signaling.  
Abbreviations: PLC – Phospholipase C; PIP2 – Phosphotidylinositol 4,5-bisphosphate; DAG – Diacylglycerol; IP3 – Inositol 

















4.1 Hookworm: Nippostrongylus brasiliensis: 
Hookworms are a major human parasite infecting an estimated 740 million people worldwide, 
causing significant morbidity primarily as a result of iron-deficiency anemia (Hotez, Brooker et al. 
2004). The two major species that commonly infect humans are Necator americanus and Ancylostoma 
duodenale however a murine model for these does not exist. Instead, the nematode parasite 
Nippostrongylus brasiliensis, which naturally infects rats but has also been adapted to infect mice, is 
commonly used in the laboratory to simulate human hookworm infections as it shares similarity in 
terms of life cycle and class of immune response (Loukas and Prociv 2001; Gause, Urban et al. 
2003). 
 
4.1.1 Life cycle of N.brasiliensis. 
N.brasiliensis infection begins when the L3 infective stage larvae penetrate the skin of the host and 
after 24-48 hours migrate to the lungs via the circulatory system. In the lungs, the L3 larvae moult 
into L4 stage larvae which are coughed up and swallowed thereby entering the jejunum where they 
develop into egg-laying adults. Eggs are passed out in faeces, hatch in the soil and develop into L3 
stage larvae which are capable of infecting the next host so as to propagate the life cycle. Adult 
worms are naturally expelled, damaged but alive, from immunocompetent mice within 2 weeks of 


















Fig 4. Life cycle of typical gastrointestinal nematode parasite such as Nippostrongylus brasiliensis 
in mammalian hosts. 
 
4.1.2 Role of immune and non-immune cells during T Helper type 2 response to 
N.brasiliensis. 
N.brasiliensis infection elicits a highly polarized T Helper type 2 immune response (TH2 characterized 
by the production of cytokines IL-4, IL-5 and IL-13 together with increased eosinophilia and IgE 
production (Urban, Madden et al. 1992). The IL-4 receptor-alpha subunit (IL-4Rα) which forms the 
receptor that binds IL-4 and IL-13, as well as the TH2 transcription factor STAT-6 are essential for 
expulsion of N.brasiliensis (Urban, Noben-Trauth et al. 1998). Interestingly, IL-13 but not IL-4 is the 
major cytokine that drives parasite expulsion as IL-4-/- mice but not IL-13-/- mice are able to 
effectively resolve the infection (McKenzie, Bancroft et al. 1998). 
The importance of IL-13 in parasite expulsion is widely accepted however there was much debate 
regarding the cellular source of this IL-13 as well as mechanisms involved in initiating a TH2 

















synthesize green fluorescent protein (GFP) have allowed researchers to identify new populations of 
IL-13 producing cells (Price, Liang et al. 2010). 
 
CD4 T cells are essential for expulsion of N.brasiliensis as depleting CD4 T cells by anti-CD4 
antibodies delays parasite expulsion as long as the antibodies are administered (Katona, Urban et al. 
1988). Nude athymic mice that lack functional CD4 T cells are also unable to clear parasites 
providing further evidence that CD4 T cells are important (Jacobson and Reed 1974). Recently, a 
new innate immune cell population has been discovered that produces high levels of IL-13 rapidly 
after N.brasiliensis infection and has been hypothesized as the main cellular sources of this cytokine 
early after infection. These new cell types termed nuocytes (Neill, Wong et al. 2010) lack expression 
of classical T and B cell markers but proliferate rapidly in response to IL-25 and IL-33 to secrete IL-
13 and are essential for expulsion of N.brasiliensis. This was shown by using Il17br-/- Il1rl1-/- mice that 
lack nuocytes and are unable to clear the parasite but when adoptively transferred with in vitro 
expanded IL-13 sufficient nuocytes achieve expulsion similar to wildtype controls (Neill, Wong et al. 
2010). Together nuocytes and CD4 T cells represent the essential component of the innate and 
adaptive immune system required for N.brasiliensis expulsion.  
Non-immune populations such as smooth muscle cells and mucus-secreting goblet cells are involved 
in mediating effector responses that ensures parasite expulsion from the gut (Anthony, Rutitzky et 
al. 2007). An increase in intestinal smooth muscle contraction is observed in response to 
N.brasiliensis infection, IL-4 and IL-13 in a STAT-6 dependent manner and is hypothesized to be 
required for physical expulsion of parasite (Zhao, McDermott et al. 2003). Apart from direct 
physiological responses, IL-4Ra signaling on smooth muscle cells also mediates TH2 immune 
response resulting in a delay in both parasite expulsion and TH2 dependent development of 

















2011). N.brasiliensis infection also results in an increase in mucus secreting goblet cells in the intestine 
and lungs which provides protection  against infection by toxic molecules in mucus such as Muc5-
AC, RELM-β (Herbert, Yang et al. 2009; Hasnain, Evans et al. 2011) and/or prevent adherence of 
the parasite in the gut (McKenzie, Bancroft et al. 1998; Finkelman, Shea-Donohue et al. 2004). 
 
4.1.3 M3 muscarinic receptor and N.brasiliensis: 
Increase in smooth muscle contractility is a characteristic feature of N.brasiliensis infection and has 
been identified as a potential contributing factor for parasite expulsion however a direct link has not 
been established (Finkelman, Shea-Donohue et al. 2004). These contractions were measured in 
jejunum sections ex vivo in response to increasing doses of acetylcholine (Zhao, McDermott et al. 
2003). Interestingly, acetylcholine stimulated intestinal smooth muscle contractions are highly 
dependent on M3 receptors as M3R-/- mice have severely reduced cholinergic contractions but still 
remain viable (Matsui, Motomura et al. 2002). However, whether this affects N.brasiliensis infection in 
vivo has not been studied. A further study in our laboratory showed that mice lacking IL-4Rα on 
smooth muscle cells (SM-MHCCreIL-4Rα-/lox) have a delayed expulsion of N.brasiliensis which is 
correlated with a reduced expression of M3 receptor (at the mRNA level) in the intestine. This 
implies a potential causal effect between delayed clearance and M3 receptor expression in the small 
intestine (Horsnell, Cutler et al. 2007). We have also shown that SM-MHCCreIL-4Rα-/lox mice have a 
delay in onset of TH2 dependent pulmonary pathology after N.brasiliensis infection 
 
4.2 Bacterial pathogen: Salmonella enterica sp. Typhimurium 
Salmonella enterica serovar Typhimurium (here referred to as S.typhimurium) is a Gram negative 
bacterium that causes non-typhoidal salmonellosis (NTS); a disease characterized by diarrheal 

















immunocompromised individuals such as those with HIV, it can be fatal (Hohmann 2001; Morpeth, 
Ramadhani et al. 2009) causing invasive NTS characterized by febrile (fever) systemic illness and a 
variety of clinical symptoms such as diarrhea, splenomegaly and anemia present in the majority of 
the cases (Feasey, Dougan et al. 2012). Invasive NTS has a high incidence of mortality causing 
deaths in 22-47% of the cases even with appropriate treatment (Gordon, Banda et al. 2002; Gordon, 
Graham et al. 2008). Apart from its lethal effects on humans, S.typhimurium is also responsible for 
disease burden in common livestock such as cattle, chickens and pigs finally making its way into 
humans through the food chain. Of particular concern is the increase in antibiotic resistance in 
S.typhimurium with certain isolates being resistant to upto four commonly used antibiotics (Threlfall 
2000).  
 
In the laboratory setting, S.typhimurium has been used extensively in murine models to study systemic 
salmonellosis (Collins, Mackaness et al. 1966; Simon, Tennant et al. 2011). The advantage of using 
this bacterium is its fast growth rate and is the same species that also infects humans making 
translational studies easier (Mittrucker and Kaufmann 2000; Mastroeni and Sheppard 2004).  
 
4.2.1 Generation of the Salmonella typhimurium ΔaroA (SL3261) mutant strain. 
S.typhimurium multiplies rapidly in vivo in mice, infecting various organs such as the liver and spleen 
and has 100% mortality within 10 days (Mittrucker, Raupach et al. 2000). To allow for longer 
observation time, a number of genetically altered strains of S.typhimurium with specific deletion in key 
pathways were generated resulting in attenuated strains which are not fatal (O'Callaghan, Maskell et 


















S.typhimurium requires certain metabolites for growth and virulence that cannot be obtained directly 
from its vertebrate host and must be synthesized de novo. Two such compounds are p-amino-benzoic 
acid (pABA) and 2,3-dihydroxybenzoate (DHB) required for synthesis of folates and an iron-
acquiring compound called enterochelin respectively (Bacon, Burrows et al. 1951; Yancey, Breeding 
et al. 1979).  pABA and DHB are synthesized from the important intermediate compound 
chorismate, a product of the aromatic synthesis (aro) pathway. Selectively deleting genes in this aro 
pathway generates auxotrophic strains of the bacteria that are unable to synthesize important 
virulence factors and thus highly attenuated. This was demonstrated in a study by Hoiseth and 
Stocker who generated a non-reverting S.typhimurium ΔaroA strain by inserting a tetracycline-
resistance transposon Tn10 into the aroA cluster of genes and selecting for tetracycline-sensitive 
strains which arise as a result of the natural DNA modification property of Tn10 (Hoiseth and 
Stocker 1981). One of the strains obtained, SL3261 is highly attenuated in vivo with no fatality at an 
infection dose of 3 X 106 bacteria i.p. compared to the parent strain which has an LD50 of less than 
20 bacteria. SL3261 is also an effective vaccine in mice providing 100% protection against oral or 
intraperitoneal challenge with lethal strains of S.typhimurium (Hoiseth and Stocker 1981). 
 
4.2.2 Role of immune cells during Salmonella typhimurium  infection. 
The natural route of infection with S.typhimurium is orally with the bacteria rapidly spreading from 
the gut via Peyer’s patches and mesenteric lymph nodes to infect organs such as spleen and liver 
(Carter and Collins 1974). S.typhimurium primarily replicates extracellularly in target organs however 
protective immunity arises from engulfment and control of bacterial replication within macrophages 
(Hsu 1989). Various murine models have been used to dissect the role for both innate and adaptive 


















Fig 5. Progression of S.typhimurium ΔaroA infection in mice as measured by bacterial burden in the 
spleen at different time points. Key immune cells and responses at each stage are indicated. 
Role of Innate immunity: 
Phagocytes such as macrophages and neutrophils respond early after infection with S.typhimurium 
and play an important role in control of bacterial growth. Neutrophils are recruited early to the site 
of infection and can readily be detected in the peritoneum 4 hours after i.p. infection and undergo a 
10-fold increase in the spleen by day 5 post-infection (Kirby, Yrlid et al. 2002). However, 
neutrophils only play a supportive function in controlling S.typhimurium infection and are not 
essential for protection (Cheminay, Chakravortty et al. 2004).   
Macrophages are also recruited early into the spleen and increase 3 fold in number by day 5 post-
infection (Kirby, Yrlid et al. 2002). Early bacterial growth is controlled by Nramp1 (Natural 
resistance associated macrophage protein 1), a cation transporter located on phagosomes in 
macrophages and is essential for protection. Inbred mice strains that have nonfunctional Nramp1 are 

















succumb to infection and die within 6 days (Vidal, Tremblay et al. 1995). Macrophages also act as a 
source of TH1 polarizing cytokines such as IL-12 and IL-18 that enhance production of IFN-γ 
required for macrophage activation and effective bacterial killing (Mastroeni, Harrison et al. 1996; 
Mastroeni, Clare et al. 1999)  
 
 
Role of Adaptive Immunity 
Innate control of bacterial replication protects mice from bacteremia, septic shock and death 
however the innate immune system on its own is not capable of eradicating S.typhimurium. The 
adaptive immune system is thus required for achieving sterile immunity as well as development of a 
memory immune response to subsequent re-infections.RAG1-/- mice which lack functional B and T 
cells but possess innate immune cells are capable of controlling attenuated S.typhimurium in the early 
stages of infection but succumb after weeks where as immune competent mice survive. 
 
The major cell type that mediates adaptive immunity to S.typhimurium is the CD4 T cells and this is 
evident from the fact that antibody mediated CD4 T cell depletion and athymic nude mice (which 
lack T cells) are characterized by higher bacterial burdens (Nauciel 1990; Sinha, Mastroeni et al. 
1997). Furthermore, TCR-αβ-/- mice which lack the classical MHCII interacting CD4 T cells are 
highly susceptible to attentuated S.typhimurium aroA but a difference in bacterial burden is only 
visible after day 21 highlighting the importance of these cells in the adaptive phase of the immune 
response. Mice deficient in other T cell types such as TCR-δ-/- (lack γδ T cells) or beta-2m-/- (lack 
CD8 T cell) mice respond similarly to wildtype mice further emphasizing the central role played by 
CD4 T cells (Hess, Ladel et al. 1996).  These essential TH1 primed CD4 T cells develop in the spleen 

















(Flores-Langarica, Marshall et al. 2011) with conventional dendritic cells required for subsequent 
maintenance of the TH1 cells (John, Rajagopal et al. 2002).  
 
S.typhimurium induces a highly polarized TH1 response and the cytokine IFN-γ is essential for control 
of bacterial replication. IFN-γ receptor deficient mice (IFN-γR-/-) whose cells cannot respond to 
IFN-γ die early within 21 days after infection with Salmonella aroA whereas wildtype mice all survive 
and clear the infection (Hess, Ladel et al. 1996). This demonstrates the critical and central role for 
IFN-γ during S.typhimurium infection. The development of TH1 responses and IFN-g producing CD4 
T cells is regulated by T-bet, a TH1 specific T-box transcription factor (Szabo, Kim et al. 2000). 
Protection against some intracellular bacteria such as Listeria monocytogenes is not dependent on T-bet 
as T-bet-/- mice are capable of clearing the infection (Way and Wilson 2004). However, development 
of an effective TH1 response to S.typhimurium is highly dependent on T-bet expression, with T-bet
-/- 
mice succumbing to infection with attenuated strains (Ravindran, Foley et al. 2005).  
 
Activation of T cells requires engagement of the TCR as well as co-stimulatory markers. An 
important co-stimulatory marker for CD4 T cells is CD28 which receives signals from professional 
antigen presenting cells via CD80 and CD86 (Lenschow, Walunas et al. 1996). Expression and 
engagement of CD28 is critical during S.typhimurium infection and CD28-/- mice die rapidly within 
the first 10 days after infection with a lethal strain. CD28-/- mice also remain chronically infected 
with an attenuated S.typhimurium strain whereas wildtype mice clear the infection within 5 weeks. 
CD28 engagement is also required to mediate T and B cell interactions for antibody class switching 
and CD28-/- mice do not produce Salmonella specific IgG1 and IgG2a antibodies (Mittrucker, Kohler 


















B lymphocytes play a more variable role depending on the strain of S.typhimurium used and the route 
of infection. Igμ-/- mice which are completely devoid of B cells and antibodies are capable of clearing 
S.typhimurium aroA infection similarly to wildtype mice. Igμ-/- mice are more susceptible to an oral 
infection with lethal S.typhimurium but die as rapidly as wildtype mice after an intravenous infection 
with the same strain suggesting that B cells and antibodies may be more effective in preventing 
certain routes of infection over others. Early during infection, S.typhimurium induces a rapid and 
massive extrafollicular plasma cell response, producing low-affinity antibodies with development of 
germinal centers and high-affinity antibody production following later during infection. Therefore, 
even though B cells and high affinity antibodies are not essential for clearance of a primary infection 
with S.typhimuirum aroA, antibodies play an important role in limiting the spread of bacteria and 
colonization of splenic macrophages (Cunningham, Gaspal et al. 2007). Salmonella outer membrane 
proteins (Omp) particularly OmpD induces a strong T cell independent antibody response from a 
subset of B cells in the peritoneum known as the B1b. These antibodies are then capable of 
providing protection against re-infection making OmpD a potential vaccine candidate (Gil-Cruz, 
Bobat et al. 2009). B lymphocytes are also important for development of memory immune 
responses to lethal S.typhimurium after vaccination with the aroA strain (Mittrucker, Raupach et al. 
2000). However, B cells can provide this post-vaccination protection independent of antibody 
production by directing an effecting T cell mediated immune response (Nanton, Way et al. 2012). 
 
The pro-inflammatory cytokine TNF-α is also involved in controlling S.typhimurium although it is not 
essential for survival. TNF receptor (TNFαp55R-/-) deficient mice are more susceptible to Salmonella 
aroA infection having a higher bacterial burden in the spleen and liver but can eventually clear the 

















after vaccination with attenuated Salmonella as all TNFαp55R-/- mice succumb to lethal infection 
compared to 100% survival in wildtype vaccinated mice (Everest, Roberts et al. 1998).  
 
 
4.2.3 Cholinergic control of Salmonella and other bacterial infections. 
Several studies have examined broadly the contribution of cholinergic system to immunity in various 
bacterial infection models. Acetylcholine is generally considered to be anti-inflammatory based on its 
action on nicotinic receptors (Tracey 2007). However raising acetylcholine levels in vivo by 
administering paraoxon, an acetylcholinesterase inhibitor, significantly improves survival after 
infection with a lethal strain of S.typhimurium (20% survival versus 80% survival after paraoxon). 
Paraoxon-administered mice also have a 10-fold lower bacterial burden in the spleen and higher 
serum levels of the TH1 polarising cytokine IL-12 (Fernandez-Cabezudo, Lorke et al. 2010). This 
effect was specific for the acetylcholinesterase inhibiting property of paraoxon as co-administration 
of K-27 which reverses the inhibition restored the susceptibility of the mice to S.typhimurium. This 
study suggests that the role of acetylcholine may vary depending on the circumstance and can also 
act as a pro-inflammatory agent (Fernandez-Cabezudo, Lorke et al. 2010). 
 
The anti-inflammatory property of nicotinic receptors inhibits immunity to bacterial infection. Mice 
deficient in the essential nicotinic subunit α7 (α7nAChR-/-) have enhanced bacterial clearance as 
shown by a lower bacterial burden in the spleen, kidney and blood after an intra-peritoneal 
Escherichia coli infection (Giebelen, Le Moine et al. 2008). Also, activation of nicotinic receptors by 
topical application of nicotine or genetically deleting catestatin (Chga-/-), a nicotinic antagonist, 

















susceptibility resulted from a direct suppression of antimicrobial peptide production in the skin 
(Radek, Elias et al. 2010). These studies provide further evidence that nicotinic receptors are anti-
inflammatory and thus prevent not only excessive inflammation during LPS induced endotoxic 







































Materials and Methods: 
 
Mice. M3R-/- mice were obtained from Dr. Jurgen Wess (NIH; Bethesda, MD) in the C57BL/6 
background and prior to use in this study were backcrossed to BALB/c background for 10 
generation. Mice were bred under specific pathogen-free conditions at the University of Cape Town 
Animal Unit and used when they were between ages 6-10 weeks. Protocols for all experiments were 
reviewed and approved by the UCT Animal Ethics committees (UCT AEC Protocols number: 
010/032 (Salmonella typhimurium) 011/008 (Nippostrongylus brasiliensis) and 011/021 (Nippostrongylus 
brasiliensis life cycle maintanence). M3R-/- mice were genotyped using the following set of primers 





N.brasiliensis life cycle maintanence: N.brasiliensis L3 stage infectious larvae were maintained by 
routine passage through female Wistar rats. Female Wistar rats (at age 7 weeks; at least 170g) were 
infected with 5000L3 larvae subcutaneously and faecal pellets collected on days 6, 7 and 8 post-
infection. Faecal pellets were soaked in water containing amphotericin-B (Fungizone, Sigma) for 1 
hour prior to processing. Pellets were meshed into a paste and spread onto a filter paper placed on 
top of a gauze-pad soaked in amphotericin-B containing water. The faecal paste was then incubated 


















and migration of these larvae to the edge of the filter paper. Filter paper edges containing L3 larvae 
were collected and transferred to a fresh petri dish, ready for infection. 
 
Nippostrongylus brasiliensis infection in mice. For primary infection, mice were infected 
subcutaneously with 500 N. brasiliensis L3 stage larvae. To enumerate adult worms, mice were killed 
at various times post-infection (p.i.), intestines opened longitudinally, incubated in 10 ml saline for 3 
hrs at 37oC to allow parasite migration out of the intestines which were then counted under a 
dissecting microscope. For secondary infections, mice were infected as in primary infections with 
500L3 larvae but treated at day 9 with ivermectin via drinking water to eliminate parasites, rested for 
28 days and re-infected with 500 L3. Larvae were recovered from lungs at day 2 post-infection by 
finely slicing the tissue placing it in 5 ml saline for 3 hours, and parasites enumerated under a 
dissection microscope. 
 
Flow cytometry. Single cell suspensions were prepared and 1x106 cells incubated in PBS + 0.1% 
BSA, 1% normal rat serum, 1% FcεRII/III (Blocking antibody) and appropriate antibody cocktails 
in a total of 50ul in 96 well V-bottomed plates for 30 mins on ice. After incubation, cells were 
washed once with 200ul ice cold FACS Buffer (PBS + 0.1% BSA) and resuspended in 200ul FACS 
Buffer for acquisition. Cell populations were determined and acquired on a BD FACS Fortessa 
(Becton Dickinson). Prior to each acquisition run of samples, compensation beads (BD CompBeads; 
BD Biosciences) stained with appropriate fluorochrome antibodies were used to obtain correct 



















The following antibodies were used in this study:  
Antibody target Fluorochrome Clone Number Company 
B220/CD45R Biotin RA3-6B2 Homemade 
CD3 AlexaFluor-700 17A2 eBioscience 
CD4 PerCP L3T4 BD Bioscience 
CD8 V500 53-6.7 BD Bioscience 
CD28 PE 37.51 BD Bioscience 
CD44 FITC IM7 BD Bioscience 
CD62L APC MEL-14 BD Bioscience 
CD19 APC 1D3 BD Bioscience 
CD11c Biotin HL3 BD Bioscience 
CD11b FITC M1/70 BD Bioscience 
Gr1 PE RB6-8C5 BD Bioscience 
F4/80 PE-Cy7 BM8 eBioscience 
TCRαβ Biotin H57-597 BD Bioscience 
IFN-γ PE XMG1.2 BD Bioscience 
TNF-α APC MP6-XT22 BD Bioscience 
 
Immune cell populations were gated as follows: 
CD4 T cells: CD3+CD4+; CD8 T cells: CD3+CD8+; B cells: CD19+B220+; Macrophages: 
CD11b+F4/80+; Dendritic cells: CD11c+  





















Fig 1: Gating strategy for immune cells in the spleen and mesenteric lymph node using flow cytometry. Splenocytes and 
lymphocytes were stained with a cocktail of antibodies including CD3, CD4, CD8, B220, CD19, CD11b, F4/80, CD11c to 
delineate important immune cell populations such as CD4 and CD8 T cells, B cells, macrophages and dendritic cells. CD4 T cells 
were also further gated to identify naïve and activated T cell populations. 
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Measurement of antibody and cytokine levels using Enzyme Linked ImmunoSorbent Assay 
(ELISA).  
96-well flat-bottom ELISA plates (Nunc Maxisorp; Thermo Fisher Scientific) were coated with 50ul 
of monoclonal coating antibodies specific for IL-13 (BD Bioscience) and IFN-γ (homemade clone: 
ANI8KL6) or total antibody isotype overnight at 4oC. For N.brasiliensis specific antibody ELISAs, 
plates were coated with 10ug/ml somatic antigen (NES) and for Salmonella specific antibody ELISAs 
plates were coated with 1 X 107 heat-killed S.typhimurium aroA per well. After overnight incubation, 
plates were blocked using 2% casein milk powder in PBS for 3 hours at 37oC. Samples were added at 
50ul per well and in three concentrations (neat, 1 in 3 and 1 in 9 diluti ns) overnight at 4oC. Each 
ELISA plate also contained a cytokine or antibody standard diluted out across one row. Next, a 
biotin conjugated polyclonal antibody specific to the cytokine IL-13, IFN-γ or antibody isotype of 
interest (BD Biosceince) was added in 50ul of FACS buffer and incubated for 3 hours at 37oC. 
Streptavidin-conjugated Horseradish Peroxidase (HRP) (KPL Inc.; MD, USA) was used for 
detection and added at a concentration of 0.02 μg/ml for 1 hour at 37oC followed by a thorough 
wash with PBS + 0.05% Triton X-100 and visualized using a commercially available substrate 
solution (KPL Inc.; MD, USA). All cytokine and antibody ELISAs had been previously optimized in 
our lab with respect to coating and secondary antibody concentrations by titration. 
For cytokine re-stimulation, spleen, mesenteric LN and lung cells were plated at 1 X 106 cells per 
well in 48 well plates pre-coated with 20 ug ml-1 anti-CD3 (homemade – clone: 17A2) and 
restimulated for 72 hrs. Homogenates of lung and intestinal sections were prepared using a Polytron 


















Blood was collected in BD Microtainer™ tubes (BD Bioscience) containing clot-activator gel and 
centrifuged at 8000 rpm for 5 mins to separate blood plasma from cellular material. Plasma was 
removed and used for determination of total and antigen specific antibody ELISA as outlined above. 
 
Cholinergic stimulation. Lymph node cells were plated at 1 x 106 cells per well in a 96 well plate 
and stimulated with 0.1 g ml-1 (sub-optimal) anti-CD3 (clone: 145-2C11), 10 M acetylcholine 
(Sigma) + 10 M BW284C51 (Sigma), 10 M Oxotremorine M (Oxo M) (Sigma), 10 M muscarine 
(Sigma) or buffer control for 24 hours. Supernatants were analysed for cytokines by ELISA as 
described.  
 
Measurement of intestinal contraction. Ileal sections (1 cm) were obtained from mice by cutting 
the intestine 10 cm from the junction with the stomach. This section was hooked onto a force 
transducer, placed in PBS maintained at 370C in an organ bath, and stimulated with ACh from 10-9M 
to 10-3M. In between stimulations, the intestinal segment was allowed to return to baseline 
contraction (at least 5 min). All measurements were recorded using the Powerlab acquisition unit 
(ADInstruments) and analysed using the Chart5 program and the amplitude measured as the 
difference between the peak and trough of the contraction reported in millinewtons (mN). 
 
Adoptive transfer of CD4 T cells. CD4 T cells were purified from MLNs by positive selection 
using CD4 MACS beads (L3T4, MACS Miltenyi, Holland) according to the manufacturer's protocol. 


















T cells from infected animals or 1x106 purified CD4 T cells from naive animals transferred into 
naive WT or M3R-/- mice intravenously. Recipient mice were infected 24 hrs later with 500 L3 and 
killed 5 days post infection. 
 
cDNA synthesis and RT-PCR. RNA was extracted using the Qiagen RNeasy Mini kit (Qiagen, 
Germany) as per manufacturer’s protocols. RNA was converted to cDNA either using random 
primers and Superscript Reverse Transcriptase (for Imperial College generated data) (Invitrogen) or 
using the Roche Transcriptor First Strand cDNA synthesis kit (Roche Applied Science) for 
quantitative PCR, which was performed on a Roche Lightcycler 480 using FastStart SybrGreen 
(Roche Applied Science) as detection dye. The following primer pairs were used:  
Gene Forward Primer Reverse Primer 
M1R 5’-GGACAACAACACCAGAGGAGA-3’ 5’-GAGGTCACTTTAGGGTAGGG-3’ 
M2R 5’-TGAAAACACGGTTTCCACTTC-3’ 5’-GATGGAGGAGGCTTCTTTTTG-3’ 
M3R 5’-TTTACATGCCTGTCACCATCA-3’ 5’-ACAGCCACCATACTTCCTCCT-3’ 
M4R 5’-TGCCTCTGTCATGAACCTTCT-3’ 5’-TGGTTATCAGGCACTGTCCTC-3’ 
M5R 5’-CTCTGCTGGCAGTACTTGGTC-3’ 5’-GTGAGCCGGTTTTCTCTTCTT-3’ 
β-actin 5’-TGGAATCCTGTGGCATCCATGAAAC-3’ 5’-TAAAACGCAGCTCAGTAACAGTCCG-3’ 
IL-13 5’-CTCCCTCTGACCCTTAAGGAG-3’ 5’-GAAGGGGCCGTGGCGAAACAG-3’ 
IFN-γ 5’-GCTCTGAGACAATGAACGCT-3’ 5’-AAAGAGATAATCTGGCTCTGC-3’ 
Tbet 5,-AACTTTGAGTCCATGTACGC-3’ 5’-TATCCTTGGGCTGGCCT-3’ 



















Histology. Lung and intestinal sections were fixed with 4% formalin in PBS solution immediately 
after dissection. After overnight fixation, sections were embedded in wax and cut into thin 5uM 
sections, then stained with Periodic Acid Schiff (PAS) stain to distinguish mucus-producing goblet 
cells. Cells containing mucus were distinguished by the dark purple colour formation following PAS 
staining. A Nikon Eclipse 90i microscope was used to capture micrographs using supplied software 
(NIS Elements; Nikon). 
 
Salmonella typhimurium aroA infection in mice: 
Salmonella enterica sp Typhimuirum aroA (SL3261) was kindly donated by Prof. Adam Cunningham 
(University of Birmingham). S.typhimurium for infection was prepared from frozen stocks and used 
during the log phase of growth. Briefly, 10mls of LB agar (10g tryptic soy broth, 5g Yeast extract 
and 10g NaCl in 1 liter distilled water autoclaved.) were inoculated with a loop of frozen 
S.typhimurium aroA and incubated at 37 oC on a shaker set at 180rpm. The absorbance (OD) of the 
bacterial culture at 600nm was monitored periodically until a value of 0.9 was reached (previously 
established as log phase growth). 1ml of the bacterial culture was removed and centrifuged at 
10,000rpm for 5 min, washed twice with sterile PBS and finally resuspended in 1ml sterile PBS. This 
bacterial stock was diluted 1 in 200 prior to infecting each mouse intrapertioneally with 200ul. The 
infectious dose was determined by plating the inoculum on LB agar plates and incubating overnight 
at 37oC. We consistently obtained an infectious dose of between 5 X 105 to 8 X 105 CFU per mouse 



















Determination of S.typhimurium aroA spleen bacterial burden: 
Mice infected with S.typhimurium aroA were killed at various time points of days 7, 18, 27 and 35 post 
infection and the spleens removed and weighed before further processing. Spleens were then cut 
into three pieces, each piece was weighed individually, and one piece used for determining bacterial 
burden. Spleen sections were processed through a 100 μm filter using 1ml of antibiotic-free media 
and transferred to a 48-well plate. Serial dilutions (1 in 10) of the spleen homogenate were 
performed upto a final concentration of 10-3. 100ul of appropriate dilution (based on day post-
infection and expected bacterial burden) was plated out on LB agar (LB tryptic soy broth + 12% 
bacterial-grade agar) and incubated overnight at 37oC. Individual bacterial colony forming units 
(CFU) were enumerated for each spleen section and back-calculated to obtain total CFU per spleen. 
 
Generation of bone marrow chimera mice with B cell specific deletion of M3R. 
We used mixed bone marrow chimeras to generate mice that lacked M3R expression only on B cells. 
Recipient B cell deficient (μMT) mice were irradiated with two doses of 500 rads (5 Grays) over 5 
mins using a 60Co source, with doses separated by 3 hours. All recipient mice were given acidified 
drinking water (100ul concentrated hydrochloric acid in 500mls drinking water) one week prior to 
and upto 10 days after irradiation. Naive wildtype, M3R-/- and μMT mice were used as donors for 
bone marrow cells which was extracted from the femur and tibia by flushing out with cold DMEM 
media containing 10% FCS.  Bone marrow (BM) cells from each strain were enumerated and mixed 
in the ratio of 80% μMT BM cells and 20% WT or M3R-/- BM cells. Recipient mice were rested 
overnight prior to transfer of 5 X 106 mixed BM cells intravenously and rested for a further 6 weeks 


















the tail vein of chimera mice and the percentage of B cells was determined using flow cytometry to 
ensure all mice were effectively repopulated. 
 
Generation of bone marrow derived macrophages (BMDM) 
Wildtype and M3R-/- mice were killed using halothane inhalation and the femur and tibia of both 
limbs were removed. Muscle tissue attached to the bone was carefully scraped off using a scalpel, 
and the femur and tibia separated at the knee joint. The top and bottom of both bones were sliced 
open, and a syringe with 20 ml of cold DMEM/10%FCS attached to a 23G needle was used to flush 
out the bone marrow into a 50 ml tube, bone marrow from all mice of the same strain were 
collected together and centrifuged at 1200 rpm for 5 min. Cells were resuspended in 10 ml of 
Pluznik media (recipe in Appendix A) which contained L929 cell line conditioned media, a source of 
M-CSF (macrophage growth factor) and counted.  A total of 6 X 106 BM cells were added to 60 ml 
of Pluznik media in special Teflon coated bags and incubated at 37oC for 10 days to allow for 
proliferation and differentiation of bone marrow cells into macrophages. For harvesting, media in 
Teflon coated bags was decanted, and the bag washed with a further 90 ml of media to maximize the 
number of macrophages being harvested. All the decanted media was pooled, centrifuged at 1200 




















In vitro BMDM kill assay with S.typhimurium aroA 
Bone marrow derived macrophages (BMDM) generated as described above were plated at 5 X 105 
cells per well in a 24 well plate and incubated overnight at 37oC to allow for macrophage adherence. 
During overnight incubation, half the BMDMs were treated with 100U/ml IFN-γ for activation and 
the other half were left untreated. The following day, cells were washed with 500 ul pre-warmed 
media and S.typhimurium aroA, from a log phase culture, was added at multiplicity of infection (MOI) 
of either 2 or 10 in a total volume of 500 ul. BMDMs and S.typhimurium were incubated for 4 hours 
at 37 oC to allow for bacterial uptake, after which the cells were washed with 100 ug/ml gentamycin 
for 2 hours to get rid of all extracellular bacteria. BMDMs were washed with media to remove the 
gentamycin and a further 500 ul of media was added. This was considered time 0 and after which 
cells were lysed at different time points by addition of 1 ml PBS with 0.05% Triton-X and the lysates 
diluted 10-fold before plating on LB agar plates. CFU was enumerated after overnight incubation at 
37oC to obtain bacterial burden at different time points. 
 
In vitro CD4 T cell differentiation into TH1 or TH2 
CD4 T cells were isolated from mesenteric lymph nodes of naïve mice using flow cytometry to 
atleast 99% purity. FACS sorted CD4 T cells from the lymph node were plated at 1 X 105 cells/well 
on 96 well plates previously coated with 10 g/ml anti-CD3 (BD Bioscience) and 5 g/ml anti-
CD28 (BD Bioscience). For TH1 polarization, cells were incubated with 5 ng/ml rIL-12 (BD 
Bioscience) and 50 μg/ml anti-IL-4 (homemade Clone: 11B11). TH2 polarization was induced by 
adding 50 ng/ml mouse IL-4 (BD Bioscience) and 50 μg/ml anti-IFN-γ. Medium alone was used as 


















were then transferred to a fresh round bottomed 96 well plate and washed with medium after which 
they were resuspended in appropriate antibody cocktails with the addition of 20 U/ml IL-2 (BD 
Bioscience) and cultured for another 48 hours. The cells were then washed with fresh medium, 
replated at 2 X 105 cells/well and incubated on 96 well plate coated with 20 μg/ml anti-CD3 (BD 
Bioscience). Supernatants were harvested after 48 hours of restimulation and used for ELISA.  
 
Statistical Analysis 
All data obtained were analysed using GraphPad Prism software Ver. 5.0 (GraphPad Software Inc. 
La Jolla, CA)and included statistical tests such as Mann-Whitney two-tailed t test and Two-way 
ANOVA. Flow cytometry data was anaylsed using FlowJo software Ver 7.6.5 (Treestar Inc. Ashland, 





















































Chapter 1: Characterization of physiology and immune cell 
populations of M3R deficient mice in the naïve state: 
 
The muscarinic receptor family comprises of a group of five subtypes, called M1-M5 (Caulfield and 
Birdsall 1998), that play important roles in regulating a diverse set of physiological functions 
including smooth muscle contractility, control of heart rate and promoting glandular secretions 
(Wess, Eglen et al. 2007). Historically, the muscarinic receptor was studied mainly done on neurons 
and its role in regulating nerve impulse transmission across synapses. However, more recently, 
studies have focused increasingly on the expression and function of muscarinic receptors on non-
neuronal cells (Kawashima and Fujii 2008). One of the subtypes, M3 muscarinic receptor (M3R), has 
been widely studied due to its presence on a number of important cells and the nature of the 
responses it regulates. The M3R plays a major role in regulating smooth muscle contraction and has 
been the target for drugs to alleviate the symptoms of asthma and overactive bladder disorder. M3R 
also plays a significant role in promoting secretions such as saliva from salivary glands and insulin 
from the pancreas (Eglen 1996; Nakamura, Matsui et al. 2004; Gautam, Han et al. 2007).  
The M3R deficient mouse (M3R-/-) strain was generated by a number of groups and has been 
instrumental in confirming known roles as well as delineating further roles for the M3R and to study 
in detail it’s mechanism of action. The M3R-/- mice used in this study were generated by our 
collaborator Dr. Jurgen Wess at the National Institute of Diabetes and Digestive and Kidney 
Disease, Bethseda, Maryland and its physiological properties have been characterized while still on a 
hybrid background of 129SvEv and C57Bl/6J (Matsui, Motomura et al. 2000; Yamada, Miyakawa et 
al. 2001). Initial studies with M3R-/- mice revealed that this mice are hypophagic (reduced feeding) 
and lean, with both male and female mice weighing about 22% less than their wildtype counterparts 


















C57Bl/6J background but in order to perform infection experiments standardized in our laboratory, 
mice were backcrossed into the BALB/c background for at least 10 generations.  
It has been known for a number of years that the M3 muscarinic receptor is expressed by immune 
cells such as CD4 T cells, CD8 T cells, dendritic cells and macrophages at the protein and mRNA 
level (Sato, Fujii et al. 1999; Kawashima, Yoshikawa et al. 2007). Subsequent work has also shown 
that in vitro activation of naïve CD4 T cells into T helper 1 (TH1), T helper 2 (TH2) or T helper 17 
(TH17) phenotype alters expression of M3R implying a possible functional role in T cell activation 
(Qian, Galitovskiy et al. 2011). However, whether these M3 receptors are required for immune cell 
development or function has not yet been conclusively determined.  
In the first chapter of this study, we aim to determine whether genotypic background of the mice 
influence some observed phenotypic changes in M3R-/- mice from previous studies. We will also 
address the effect of M3 receptor deletion on development and function of major immune cell 
populations in vivo.  
2.1 Backcrossing M3R-/- from C57BL/6 to BALB/c background maintains 
hypophagic phenotype and decreased intestinal smooth muscle contraction: 
The gene for the M3 muscarinic receptor was deleted using a targeting vector to replace a 1.6kb 
XbaI/Sse83371 fragment of the M3R gene, which contained the translation start site, and 
introduced into a TC1 (129SvEv) embryonic stem cell by electroporation (Fig 1a).  The targeting 
vector also contained two copies of the herpes simplex virus thymidine kinase gene and a neomycin 
resistance gene (neo) to allow for selection of successfully transformed embryonic stem cells (Fig 1a). 
The M3 muscarinic receptor deficient mice (referred to from now as M3R-/-) had normal fertility and 


















To determine whether backcrossing had maintained the deleted M3R allele we designed a multiplex 
PCR genotyping protocol using the primer set A1, A2 and A3 (sequence in Material&Methods) 
which yielded a 226 bp product for WT mice and a 170 bp product for M3R-/- mice Fig. 1B). This 
was confirmed by both melt curve analysis (real-timePCR) and running the PCR products on an 
agarose gel (Fig. 1C).  
This study was done on C57BL/6 mice and therefore to determine whether genetic background 
switching to BALB/c influenced this phenotype, we weighed male and female M3R-/- mice (after 10 
generations backcrossing into the BALB/c background) for 13 weeks post birth. We found that 
both male and female M3R-/- had a significantly lower body weight compared to age matched 
wildtype BALB/c mice (Fig 1D) and this decrease (22% in males and 18% in females) is similar to 
values reported in other studies (Yamada, Miyakawa et al. 2001) implying that BALB/c M3R-/- mice 




















Fig 1.1 Generation, genotyping and characterization of M3R deficient mice (M3R-/-) after backcrossing into BALB/c 
background (A) A schematic showing the generation of M3R-/- mice where the M3R gene was disrupted by replacing part of 
the coding sequence with a targeting vector containing neomycin resistance cassette. (Yamada, Miyakawa et al. 2001) (B) 
Design of the primer set for genotyping used to differentiate between normal M3R gene (WT) and disrupted M3R gene    
(M3R-/-).  (C) Mice were genotyped based on a difference in PCR product size (i) using agarose gel electrophoresis or melting 
point (ii) determined by melt curve analysis (D) WT and M3R-/- mice, born on the same day were weighed regularly from 3 
weeks (post weaning) up to 13 weeks of age while being fed ad-libitum and the body weights plotted as shown. Data are shown 
as mean ± SEM and is representative of two independent experiments with 4 mice in each group. Statistical significance was 



















2.2 M3R deletion does not affect development of immune cell populations in naïve 
mice: 
M3 receptors are expressed on a number of non-neuronal cells including importantly immune cells. 
At the transcription and protein level, M3 receptors have been shown on T cells, macrophages and 
dendritic cells (Kawashima, Yoshikawa et al. 2007; Qian, Galitovskiy et al. 2011). However, a 
functional role for M3R on immune cells has yet to be identified. Other muscarinic receptors 
notably M1R have been implicated in differentiation into cytolytic CD8 T cell in vitro (Zimring, Kapp 
et al. 2005) but this function was not replicated in vivo using an M1R/M5R double knockout mice 
(Vezys, Masopust et al. 2007). To determine whether M3R plays a role in development of major 
immune cell populations we examined proportions and numbers of the major immune cell types 
such as CD4 T cells, CD8 T cells, B cells, dendritic cells and macrophages in two important immune 
organs, spleen and lymph nodes. These different cell types were identified on a flow cytometer using 
the following markers: CD3+CD4+ (CD4 T cells); CD3+CD8+ (CD8 T cells); CD19+B220+ (B 
cells); CD11c+ (Dendritic cells) and F4/80+CD11b+ (macrophages) (Fig 1.2D).  
Spleens of M3R-/- mice (0.096g±0.01g) were significantly smaller, weighing 30% less than WT 
spleens (0.143g±0.01g) (Fig 1.2Ai) however there was no significant difference in cellularity 
(Fig1.2Aii). The smaller spleen weight of M3R-/- mice can be explained by a similar difference in 
body size compared to WT mice.  When the absolute numbers of immune cell types were examined 
in the spleens of naïve WT and M3R-/-, similar numbers were obtained for CD4 T cells, CD8 T cells, 
B cells, macrophages and Dendritic cells (Fig 1.2B.i.). Similarly, in the mesenteric LN (MLN) there 
were equivalent proportions of CD4 T cells, CD8 T cells and B cells (Fig 1.2B.ii.). Therefore, despite 
studies showing expression of M3R on these immune cell types, there was no developmental defect 
in the absence of M3R. We also examined the proportion of activated (CD44hiCD62Llo) and naïve 


















naïve mice. No difference was found between WT and M3R-/- CD4 T cells and thus M3R deletion 
does not affect basal CD4 T cell activation (Fig 1.2C. i and ii). Finally, we examined whether M3R 
deletion affects differentiation of CD4 T cells into either the T helper 1 or T helper 2 phenotype in 
vitro. Isolated MLN WT and M3R-/- CD4 T cells were incubated with IFN-γ and anti-IL-4 antibody 
(TH1 condition) or IL-4 and anti-IFN-γ antibody (TH2 condition) for 5 days after which cells were 
transferred to a fresh plate and stimulated with anti-CD3 and anti-CD28 for 3 days. Degree of 
differentiation was determined by measuring IFN-γ or IL-4 production after stimulation and similar 
levels were produced by WT and M3R-/- CD4 T cells under TH1 (IFN-γ) and TH2 (IL-4) conditions 
(Fig 1.2D). Thus, there is no defect in TH1 or TH2 differentiation by CD4 T cells in the absence of 




















Fig 1.2.  M3R does not affect development of immune cell populations in spleen and mesenteric lymph nodes 
(MLN) in naïve mice (A.) Spleens from WT and M3R-/- mice were weighed and then processed to single cell suspension to 
determine (ii) spleen cellularity. (B.) (i) The numbers of major immune cell populations namely CD4 T cell, CD8 T cell, B cell, 
macrophages and dendritic cells in the spleen were determined in WT and M3R-/- naïve mice using specific cell surface markers 
on a flow cytometer. (ii) Proportion of B cells, CD4 and CD8 T cells in the MLN were determined by flow cytomtery. (C) 
Proportion of activated and naïve CD4 T cells were determined for (i) spleen (ii) MLN by first gating on CD3+CD4+ T cells 
followed by gating on activated (CD44hiCD62Llo) and naïve (CD44loCD62Lhi). (D.) Isolated WT and M3R-/- CD4 T cells from 
MLN were subjected to TH1 or TH2 differentiation in vitro using a cocktail of cytokines and antibodies as outlined in Materials 
& Methods section. Data are shown as mean ± SEM and is representative of two independent experiments with 6 mice in each 



















2.3 M3R deficiency affects expression of co-receptors CD28 and TCRαβ on 
CD4 T cells in naïve mice. 
We have shown that M3R deletion is not required for development of major immune cell 
populations including activated and naïve subsets of CD4 T cells in the spleen and mesenteric lymph 
node despite published studies indicating expression of M3R by these cells (Qian, Galitovskiy et al. 
2011). Despite no apparent differences in basal activation of CD4 T cells, it is possible that M3R 
exerts its effects at the level of expression of immune receptors on the surface of CD4 T cells such 
as the co-receptors TCRαβ and CD28 thereby impacting the quality of induced T cell activation. 
TCRαβ and CD28 are essential co-receptors for antigen recognition and activation of CD4 T cells 
by Antigen Presenting cells (APC) (Ward 1996; Jenkins, Khoruts et al. 2001). Splenocytes and MLN 
cells from naïve mice were stained with CD3, CD4, CD44 and CD62L antibodies to delineate 
populations of activated and naïve CD4 T cells using flow cytometry. Cells were also stained with 
antibodies for co-receptors CD28 and TCR with relative expression levels determined by 
geometric mean (Geo Mean). Interestingly, M3R-/- CD4 T cells from both the spleen and MLN 
displayed significantly reduced expression of CD28, and furthermore this reduction was most 
prominent in the activated (CD44hiCD62Llo) subset of CD4 T cells (Fig 1.3A). Meanwhile, TCR 
expression was more similar between WT and M3R-/- CD4 T cells, except for activated CD4 T cells 
in the spleen where it was marginally, but significantly, higher on M3R-/- CD4 T cells (Fig 1.3A). 
Since CD28 ligation by the co-stimulatory molecules CD80/CD86 on APCs is an essential step for 
CD4 T cell activation (Lenschow, Walunas et al. 1996), reduced expression may result in defective T 




















Fig 1.3 M3R deficiency affects expression of co-receptors CD28 and TCRαβ on CD4 T cells in naïve mice (A) 
Geometric means of CD28 and TCRab expression on total CD4 T cells, activated (CD44hiCD62Llo) and naïve 
(CD44loCD62Lhi) CD4 Tcells derived from spleen and mesenteric lymph nodes of naïve uninfected mice. (B) 
Representative histograms showing CD28 and TCRab expression on activated CD4 T cells from the spleen and MLN of 
WT (solid line) and M3R-/- mice (dashed line). Cells were stained with an antibody panel consisting of CD3, CD4, CD44, 
CD62L, CD28 and TCR, acquired on a BD Fortessa and analysed using FlowJo software. Data is shown as mean ± SEM 
and is from one experiment with 6 mice in each group. Statistical significance was calculated using the Mann-Whitney two-
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3.  Discussion: 
 
Muscarinic receptors and particularly the M3 receptor subtype exist on a number of non-neuronal 
cells such as smooth muscle cells, insulin-secreting β cells in the pancreas and immune cells. The 
function of M3R has been well characterized for smooth muscle contraction and glandular 
secretions however its role on immune cells is not known. Therefore in our study, we set out to 
elucidate a role for the M3R in controlling immune cell functioning using targeted gene deficient 
mice lacking the M3R (M3R-/-) and a number of murine models of infectious diseases. The M3R-/- 
mouse strain was generated and kindly given to us by Dr Jurgen Wess in the C57BL/6 background. 
In order to perform standardized experiments using model pathogens in our laboratory, the M3R-/- 
mice first had to be backcrossed to the BALB/c background for at least 10 generations prior to use. 
In the first chapter, we present data to determine whether the M3R-/- mice still retain the major 
phenotypes reported for this mouse strain as well as to characterize the development of major 
immune cell populations in the naïve state (i.e prior to infection with model pathogens). We found 
that M3R-/- mice even in the BALB/c background maintained their distinct hypophagic and lean 
phenotype with both male and female mice weighing approximately 20% less than their wildtype 
counterparts as reported previously (Yamada, Miyakawa et al. 2001). We also obtained the expected 
product sizes using the genotyping primers designed to detect the wildtype and modified allele 
confirming that backcrossing into BALB/c has maintained the M3R deletion genetically as well as 
phenotypically. 
The existence of both subtypes of acetylcholine receptors, nicotinic and muscarinic, has been 
reported on immune cells (Kawashima, Yoshikawa et al. 2007). An important anti-inflammatory role 


















macrophages. Muscarinic receptors have also been found on numerous immune cells, both from 
murine and human primary and immortalized cell lines. A muscarinic subtype, the M1R, is required 
for development of CD8 T cells in vitro, however in vivo mice lacking the M1R were able to generate 
fully functional CD8 T cells. M3R in particular have been found in CD4 T cells, CD8 T cells (Qian, 
Galitovskiy et al. 2011), B cells (Fujii and Kawashima 2000), dendritic cells and macrophages 
(Kawashima, Yoshikawa et al. 2007). Using M3R-/- mice we showed that M3R was not required for 
development of major immune cells such as CD4 T cell, CD8 T cell, B cells, macrophages and 
dendritic cells in the spleen or lymph nodes as both wildtype and M3R had similar proportions and 
number of immune cells in the lymphoid organs examined. We also focused on subsets of CD4 T 
cells and found that under specific pathogen free condition (SPF) the M3R mice were able to 
maintain basal levels of T cell activation as measured by CD44hi and CD62Llo expression. We further 
tested whether functionally M3R were required for CD4 T cells to develop into either TH1 or TH2 
phenotype in vitro. Using a cocktail of antibodies and cytokines, we found that naïve M3R-/- CD4 T 
cells are fully capable of generating a TH1 or a TH2 equivalent to wildtype CD4 T cell.  Therefore, it 
appeared that even though a number of immune cells express the M3R, it was not required for their 
development and in the case of CD4 T cells did not prevent development of a T helper 1 or 2 type 
of response in vitro. Muscarinic receptors, like other G protein coupled receptors (Ritter and Hall 
2009) interact with a number of other proteins such as ion channel proteins, scaffolding proteins 
and other membrane receptors (Borroto-Escuela, Agnati et al. 2012). M3R has also been shown to 
interact with and modulate mammalian odorant receptor signaling (Li and Matsunami 2011). We 
therefore investigated whether M3R deficiency affects expression of two key co-receptors, TCRαβ 
and CD28, on the surface of CD4 T cells. In naïve mice, M3R-/- CD4 T cells and mainly the 
activated CD4 T cell subset express significantly lower levels of CD28 but not TCRαβ on both 


















co-stimulatory molecules CD80/CD86 on APCs to initiate an immune response (Lenschow, 
Walunas et al. 1996). Lower levels of CD28 expression may be indicative of a reduced potential for 
CD4 T cell activation and subsequent dampening or delay of immune responses. In order to 
investigate this further, we employed the use of murine infectious pathogens to study the role of 



















Chapter 2: Role of M3R in regulating TH2 immunity after infection with 
Nippostrongylus brasiliensis. 
1. Introduction: 
In the previous chapter, we determined that naive M3R-/- mice did not have any obvious defect in 
basal development of immune cell populations. However it still remains to be determined whether 
M3R deletion influences the development of an immune response following a pathogenic infection.  
 
In this chapter, we aimed to determine the contribution of M3R signalling to immunity induced by 
Nippostrongylus brasiliensis by utilising M3R gene deficient mice (M3R-/- mice). Nippostrongylus brasiliensis 
is a common laboratory pathogen used to study T helper 2 immune response mediated disease 
resolution and closely resembles the important human hookworms Ancylostoma duodenale and Necator 
americanus (Gause, Urban et al. 2003), which affects up to two billion people in the world and is 
responsible for severe economic losses in livestock (Hotez, Brindley et al. 2008). The nematode 
parasite N.brasiliensis induces a TH2 response in murine hosts, with IL-13 signalling via 
IL4Ressential for clearance of infection (Urban, Noben-Trauth et al. 1998). This pathway is also 
necessary for enhanced smooth muscle contractility, thought to be an important factor in expelling 
parasites from the intestine (Zhao, McDermott et al. 2003; Akiho, Lovato et al. 2005). Previous 
studies in our laboratory using mice with smooth muscle cells deficient in IL-4R showed delayed 
parasite expulsion. Associated with this deficit was reduced TH2 cytokine production in mesenteric 
lymph nodes, delayed goblet cell hyperplasia, and reduced intestinal M3 muscarinic receptor (M3R) 
expression (Horsnell, Cutler et al. 2007). This was an interesting finding, as the M3R is the major 
mAChR expressed on smooth muscle, and has been shown to drive most of the contractile response 


















function, the study revealed a surprising effect of M3R deficiency on adaptive immune responses 
elicited in vivo during infection with N. brasiliensis particularly related to CD4 T cell function. 
 
2. Results: 
2.1. Absence of M3R results in delayed parasite expulsion and reduced TH2 
cytokine production after a primary N.brasiliensis infection. 
To determine whether expression of M3 receptor is important for in vivo immunity to N. brasiliensis, 
we infected M3R-/- with 500L3 larvae and examined parasite burden at day 7, 9 and 12 post 
infection. At 7 days post infection M3R-/- mice had a 2-fold higher adult worm burden in the small 
intestine compared to WT mice. In normal wildtype (WT) BALB/c mice, the infection is self-
resolving and the parasites are cleared from the small intestine by day 9. However, expulsion of 
parasites was delayed in the M3R knockout mice (M3R-/-) with adult worms recovered at day 9 
where as none were recovered from WT mice but by day 12 M3R-/- mice had also cleared the 
infection (Fig. 2.1 A).  
Increased intestinal hypercontraction in response to carbachol, a cholinergic agonist, has been 
observed during N. brasiliensis infection and is hypothesised to be a potential effector mechanism for 
parasite expulsion (Rodriguez-Palmero, Hara et al. 1999). M3R-/- mice have previously been shown 
to be refractory to ACh-induced hypercontractility (Matsui, Motomura et al. 2002). We observed 
increased ACh-driven hypercontraction in infected wildtype mice but this was completely abrogated 
in infected M3R-/- mice (Fig. 2.1 B), suggesting that M3R-mediated hypercontractility of smooth 
muscle may indeed contribute to parasite expulsion but is not essential as M3R-/- mice are totally 


















Next we investigated whether M3R influences the development of TH2 immune responses which 
may contribute to the observed delay in expulsion of N.brasiliensis. Analysis of whole tissue cytokine 
levels in the intestine revealed a trend for reduced IL-13 levels in M3R-/- compared to WT mice at 
day 7, although this did not reach statistical significance, with no difference observed at day 9 post-
infection (Fig. 2.1 Ci). IL-13 was also significantly reduced 3-fold at the transcript level in isolated 
MLN CD4 T cells from M3R-/- mice at day 7 (Fig. 2.1 Cii) suggesting that the defect in parasite 
expulsion may be immune driven. To further characterize the CD4 T cell phenotype in the absence 
of M3R, we used flow cytometry to determine CD4 T cell activation and costimulatory marker 
expression. There was a higher percentage of CD4 T cells in the MLN of M3R-/- mice but a lower 
proportion of these cells were activated as defined by markers CD44hiCD62Llo indicating a possible 
defect in activation but not development in the absence of M3R (Fig. 2.1 D). The proportion of 
naïve CD4 T cells, defined by CD44loCD62lhi, in contrast were significantly higher in M3R-/- mice 
further supporting the claim that in the absence of M3R, CD4 T cell activation is attenuated (Fig 
2.1D).  CD4 T cells and in particular the activated CD4+CD62Llo T cells had a lower expression of 
the co-stimulatory marker CD28 (Fig. 2.1E). This reduced CD28 expression may explain the defect 
in TH2 cytokine production as ligation of this receptor is important for TH2 differentiation and 
production of associated cytokines such as IL-4 and IL-5 by CD4 T cells in vitro and in vivo (Rulifson, 
Sperling et al. 1997; Rodriguez-Palmero, Hara et al. 1999). These data indicate that expulsion of 
N.brasiliensis and production of IL-13 is delayed in M3R-/- mice, suggesting that expression of M3R 
on CD4+ T cells is required for optimal IL-13 production possibly via CD28 co-stimulation in 


















      
  
Fig 2.1. M3R deficient mice have delayed clearance of a primary N.brasiliensis infection. (A)  Adult worms in the 
intestine were enumerated at days 7, 9 and 12 post-infection in WT (white bar) and M3R-/- (black bar) mice. (B) Contraction 
of jejunum sections in response to varying doses of acetylcholine measured using a force transducer at day 9 post-infection. (C) 
(i) IL-13 in intestinal homogentaes (5mg/ml final protein conc at days 7 and 9 post-infection detected by ELISA. (ii) IL-13 
mRNA in sorted CD4 T cells from MLN  of WT and M3R-/- mice at day 7 post  infection. (D) Percentage of CD4 T cells in 
MLN at d7 p.i and  proportion of activated CD4 T cells (CD3+CD4+CD44hiCD62Llo)  within total CD4 T cells.                    
(E) Expression of the co-stimulatory marker CD28 on total CD4 T cells and activated CD4 T cells. Data are shown as mean ± 
SEM and is representative of two independent experiments with 6 mice in each group. Statistical significance was calculated 
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2.2.  M3R expression is increased on CD4 T cells after N.brasiliensis infection.  
CD4 T cells express M3R and differentiation of CD4 T cells to TH1, TH2 or TH17 phenotype in vitro 
using appropriate cytokine mixes results in downregulation of M3R both at the transcript and 
protein levels (Qian, Galitovskiy et al. 2011). However, regulation of M3R on CD4 T cells in vivo 
after infection is not known. Therefore we used flow cytometry and RT-PCR to further characterize 
the expression of M3R on CD4 T cells after N.brasiliensis infection. An antibody that detects cell 
surface M3R specifically by flow cytometry is not commercially available and therefore we used the 
pan-muscarinic receptor antibody M35 which detects all subtypes (Carsi-Gabrenas, Van der Zee et 
al. 1997). At day 7 post-infection with N. brasiliensis, there was a two-fold increase in the number of 
muscarinic receptor positive CD4+ T cells in the MLN compared to normal uninfected control 
mice (Fig. 2.2 Ai), and the vast majority of these cells produced IL-4 (Fig. 2.2 Aii). Analysis of 
muscarinic receptor expression by PCR showed that T (CD90+) cells isolated from MLN expressed 
M1, M3, M4 and M5 receptor subtypes (Fig. 2.2 Bi). Moreover, expression of the M3 receptor as 
measured by real-time PCR was significantly increased 3-fold on CD3+CD4+ T cells from MLN of 
infected mice (Fig. 2.2 Bii). This is in contrast with the reported in vitro situation where M3R 
expression was reduced after TH2 differentiation of CD4 T cells using IL-4 and anti-IFN-γ 





















Fig 2.2: Muscarinic receptors are associated with TH2 cytokine production after N.brasiliensis infection. 
(A) (i) Muscarinic receptor expression on  CD4 T cells in the MLN after infection is determined by flow 
cytometry and staining with M35, a nonspecific muscarinic receptor antibody. (ii) Muscarinic receptor positive 
and negative CD4 T cells were examined for intracellular cytokine production. (B) (i) Semi- quantitative PCR of 
muscarinic receptor subtypes and (ii) Quantification of relative M3 receptor muscarinic expression in mRNA 
extracted from  MLN CD4 T cells from naive mice and after infection with N.brasiliensis. Data are shown as mean 
± SEM and is representative of two independent experiments with 5-6 mice in each group. Statistical significance 



















2.3.  Muscarinic receptor stimulation enhances TH2 cytokine production. 
CD4 T cells upregulate expression of muscarinic receptors particularly M3R after infection with 
N.brasiliensis. To determine whether these receptors are functional, we restimulated MLN cells of 
infected mice with suboptimal anti-CD3 (0.1μg/ml) in the presence of the muscarinic receptor 
agonists acetylcholine, muscarine and oxotremorine-M. Treatment with all three agonists at a 
concentration of 10μM enhanced production of the TH2 cytokines IL-4 and IL-13 by 2-fold (Fig 
2.3A). Furthermore for muscarine, the prototypical muscarinic receptor agonist, this increase was 
dose dependent and specific for TH2 cytokines but not for IL-2 or the TH1 cytokine IFN-γ (Fig 
2.3B). Production of IL-13 is significantly reduced in M3R-/- MLN cells after sub-optimal CD3 
stimulation providing a potential cause for reduced IL-13 in the intestine of M3R-/- mice. 
Interestingly, the stimulation of M3R-/- cells with the cholinergic agonist acetylcholine, together with 
the acetylcholinesterase inhibitor BW (to increase half-life of acetylcholine) (Bois, Hummel et al. 
1980), does not result in IL-13 enhancement providing strong evidence that M3R is the key 
muscarinic subtype regulating this process. This was also observed for the muscarinic receptor 
specific agonist oxotremorine-M. Furthermore, treatment of wildtype mesenteric lymph node cells 
with atropine, a muscarinic antagonist, completely abrogated agonist mediated cytokine 
enhancement (Fig 2.3C). These data confirm that muscarinic receptors and M3R in particular are 























Fig 2.3: Muscarinic receptor stimulation with agonist enhances TH2 cytokine production after N.brasiliensis 
infection dependent on M3R. (A) IL-4 and IL-13 produced by restimulated CD4 T cells isolated from MLN cells after 
N.brasiliensis infection and after treatment with various muscarinic receptor agonists acetylcholine (Ach), muscarine and 
oxotremorine-M (at 10uM each) and measured by specific ELISA. (B)  Dose dependent effect of muscarine treatment on 
cytokine production by MLN cells. (C) Muscarinic agonist acetylcholine (with BW – Acetylcholinesterase inhibitor), 
oxotremorine-M and antagonist atropine (AT) treatment of mesenteric LN cells in the absence of M3R. IL-13 was measured 
in the supernatant after 24 hours Data are shown as mean ± SEM and is representative of two independent experiments. 



















2.4.  Absence of M3R significantly impairs memory immune response during a 
secondary N.brasiliensis infection. 
CD4 T cells co-ordinate the adaptive phase of the immune response and are also important for 
immunological memory against N.brasiliensis and provide protection in mice during re-infection 
(Harvie, Camberis et al. 2010). We next investigated whether expression of the M3R influenced 
recall immune responses following secondary infection with N. brasiliensis. WT and M3R-/- mice were 
infected subcutaneously with 500 infective larvae (L3), treated with ivermectin 10 days post-
infection, rested for 28 days and then re-infected with 500 L3. Much higher numbers of parasites 
were recovered from the lungs of M3R-/- mice at day 2 post-infection compared to WT mice (Fig. 
2.4 A). This was accompanied by significantly reduced levels of IL-4 and IL-13 in lung and intestinal 
homogenates from M3R-/- mice after secondary infection (Fig. 2.4 B). As expected, infection 
resulted in a dramatic increase in the numbers of mucus-producing goblet cells in the airway 
epithelia of WT mice, but these were notably absent in the lungs of M3R-/- mice (Fig. 2.4 C). Mucus 
secretion by goblet cells has long been suggested as an effector mechanism against N. brasiliensis and 
other enteric nematodes (Miller, Huntley et al. 1981). Recent work has confirmed this, as mice 
deficient in expression of the mucins Muc2 and Muc5A exhibit delayed expulsion of a number of 
nematode species, and Muc5A was also demonstrated to have a direct detrimental effect on parasite 
viability (Hasnain, Wang et al. 2010; Hasnain, Evans et al. 2011).  
It has recently been demonstrated that the lung is a critical site for priming CD4+ T cell mediated 
immunity to N. brasiliensis (Harvie, Camberis et al. 2010), and that lung-resident CD4+ T cell 
populations are responsible for co-ordinating recall responses (G. Le Gros, International 
Immunology meeting Kobe Japan). However, total and activated CD4+ T cell populations in the 
lung, the latter identified by expression of CD62L, were similar in WT and M3R-/- mice (Fig. 2.4 D). 


















memory response in the lung after a secondary N. brasiliensis challenge, and that this involves timely 
production of IL-13 and hyperplasia of mucus-secreting goblet cells.  
 
  
Fig 2.4 M3R deficient mice have impaired memory immune responses during a secondary infection with 
N.brasiliensis.  (A) Number of N.brasiliensis larvae in the lung at day 2 post-secondary infection. (B) Levels of cytokine 
IL-4 and IL-13 in total lung and intestinal homogenates at day 2 pi. (C) Lung histological sections stained with Periodic 
Acid Schiff (PAS) stain at day 2 pi. Arrows indicate mucus producing-goblet cells. (E). Analysis of total and activated 
CD4 T cells expressed as a percentage of total cells in the lung at day 2 post-secondary infection. Data are shown as mean 
± SEM and is representative of two independent experiments with 6 mice in each group. Statistical significance was 
calculated using the Mann-Whitney two-tailed t test and denoted by * p<0.05, ** p<0.01.  
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2.5.  Expression of M3R is essential for producing functional CD4 T cells in vivo. 
CD4+ T cells are required for primary resolution of N. brasiliensis, as CD4+ T cell depleted mice are 
unable to expel parasites (Hamilton, Loose et al. 1997) and may also be important in facilitating 
memory immune response. Since M3 receptors are significantly upregulated on CD4 T cells after N. 
brasiliensis infection and CD4 T cells are important in mediating adaptive immune response, we 
investigated whether M3R expression is required on CD4 T cells to confer protection against N. 
brasiliensis in vivo. CD4 T cells were sorted from the MLN of infected WT and M3R-/- mice at day 7 
p.i. and 5 X 105 CD4 T cells were then adoptively transferred into naive BALB/c recipient mice 
which were then infected with 750L3 larvae. On day 5 p.i, adult worm burdens in mice receiving WT 
CD4 T cells were significantly lower compared to control BALB/c having received no cells (Fig 
2.5A). However recipient mice receiving M3R-/- CD4 T cells had similar worm burdens to control 
Balb/c mice indicating that no protection was provided by the transfer of M3R-/- CD4 T cell (Fig 
2.5A). Furthermore, restimulated splenocytes from recipient mice with WT CD4 T cells produce 
more IL-13 as compared to M3R-/- CD4 T cell recipients which had levels similar to naive mice that 
had not received any cells (Fig 2.5B). WT CD4 T cell recipients also had fewer total and activated 
CD4 T cells in the spleen (Fig 2.5C) and lungs (Fig 2.5D) compared to M3R-/- CD4 T cell recipient 
mice and naive BALB/c mice. This implies that M3R-/- CD4 recipients had to mount a much 
stronger cellular response in response to N.brasiliensis infection as a result of higher parasite burden 
compared to WT CD4 T cell recipients further supporting their increased susceptibility. Hence we 
can conclude that M3R deletion results in defective CD4 T cells that are unable to confer protection 





















Fig 2.5. Adoptively transferred CD4 T cells from infected M3R-/- mice do not confer protection against 
N.brasiliensis in vivo. (A) Number of adult worms in the intestine  at day 5 post infection of naive Balb/c mice were 
determined after transfer of 5 X 105  CD4 T cells from either infected WT or M3R-/- mice (B) (i) IL-13 levels  in 
supernatant of MLN cells after anti-CD3 restimulation of splenocytes were determined by ELISA. (ii) IL-13 levels in 
whole lung and intestinal homogenates (5 mg/ml) were determined by ELISA. Numbers of total and activated CD4 T 
cells were determined in the (C) spleen and (D) lung of recipient mice at day 5 post-infection with N.brasiliensis. Data are 
shown as mean ± SEM and is representative of two independent experiments with 5-6 mice in each group. Statistical 
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In this chapter we provide comprehensive characterization of the role of M3 muscarinic receptor 
following a pathogenic infection using a nematode parasite Nippostrongylus brasiliensis, as a model 
pathogen. N.brasiliensis induces a strong TH2 response with the cytokine IL-13 being essential for its 
expulsion and in a previous study from our lab we have demonstrated that gene deficient mice that 
have a delayed clearance of N.brasiliensis also express lower levels of M3R mRNA in the small 
intestine. Our current data extends the previous study by showing that M3R-/- mice are more 
susceptible to N.brasiliensis during both primary and secondary infections and muscarinic receptors, 
particularly the M3 muscarinic receptor, enhances the TH2 immune response during infection. This 
highlights an opposing effect of the two acetylcholine receptor subtypes, as nicotinic receptors have 
a well-documented role for inhibiting immune responses. This study therefore expands the paradigm 
of cholinergic signalling on development of immunity to cover not only anti-inflammatory but also a 
pro-inflammatory role for the cholinergic-immune system interaction. In a previous study, 
administration of muscarinic antagonist atropine significantly attenuated inflammation in vivo in 
response to turpentine suggesting a potential pro-inflammatory role for muscarinic receptors 
(Razani-Boroujerdi, Behl et al. 2008). However, we demonstrate this conclusively using a transgenic 
mouse strain lacking M3R and in the context of a pathogenic infection. We show that in vivo, the 
M3R is important for optimal expulsion of parasites from the intestine, associated with increased IL-
13 production. Importantly, the absence of M3R had a profound effect on activation of CD4 T cells 
from the mesenteric lymph node. This was also correlated to a lower expression of the co-
stimulatory receptor CD28 on the CD4 T cells however whether this is a cause or effect of the 
absence of M3R has yet to be determined. CD28 is essential for TH2 differentiation (Rulifson, 


















N.brasiliensis expulsion and IL-13 production from CD4 T cell (data not shown, part of H.Ndlovu 
PhD Thesis in submission). M3Rs are important in primary resolution of N.brasiliensis however, the 
role of M3Rs is more apparent during secondary infection, where recall responses in the lung are 
important (Harvie, Camberis et al. 2010). M3R deficient mice are highly susceptible to secondary 
infection with a four-fold higher parasite burden by the second day of infection. The amount of TH2 
cytokines, both IL-4 and IL-13, were also reduced in the lung of M3R-/- mice resulting in a severely 
reduced goblet cell hyperplasia and mucus production in the airways. The attenuated activation of 
CD4 T cells in M3R-/- mice prompted us to examine the dynamics of M3R expression on this cell 
type in more detail. We show that mRNA for M3R is upregulated on CD4 T cells after infection 
with N. brasiliensis, and that muscarinic agonists act as a co-stimulatory signal for type 2 cytokine 
production by lymphocytes. Acetylcholine stimulates increased production of IL-13 from mesenteric 
lymph node cells of infected mice. Since acetylcholine is the major natural ligand for cholinergic 
receptors, this effect could result from stimulation of nicotinic or muscarinic receptors. However, 
the enhancement in cytokine production was completely abrogated in the presence of the muscarinic 
receptor specific antagonist atropine or in M3R-/- lymphocytes. Therefore, this is conclusive 
evidence that M3 muscarinic rec ptor is functional on lymphocytes and responds to stimulation by 
enhancing the production of TH2 cytokines such as IL-13. 
 Finally, we show that M3Rs are required for effective CD4 T cell functioning in recall immunity. 
CD4 T cells with functional M3R were able to confer significant three-fold protection when 
transferred into N.brasiliensis infected naive mice, a protective effect that was lost when M3R 
deficient CD4 T cells were transferred. Transfer of M3R sufficient CD4 T cells was also correlated 


















 Functionally selective M3R antagonists are widely used clinically as bronchodilators to treat 
asthma and chronic obstructive pulmonary disease (Moulton and Fryer 2011). The development of 
M3R-selective agonists is currently the goal of many academic and industrial laboratories (Wess, 
Eglen et al. 2007). Our findings suggest that such compounds may improve adaptive immunity, 
providing a rational basis for the development of novel classes of drugs aimed at enhancing immune 
function in various pathophysiological conditions. 
Our findings demonstrate a striking effect on TH2 immunity and also on fundamental immune cell 
function, namely CD4 T cell actvation and co-stimulation as well as cytokine production from 
lymphocytes. These findings may suggest that the influence exerted by M3R signalling is not 
confined to TH2 immunity and may a have broader fundamental influence on immunity. Therefore, 
in order to determine whether the effect of M3R is localized to TH2 responses or extends more 
broadly to TH1 pro-inflammatory immune response and other classes of pathogens, we used a model 



















Chapter 3: Role of M3R in regulating TH1 immunity after infection 
with a bacterial pathogen Salmonella enterica sp. Typhimurium 
ΔaroA. 
1. Introduction 
In the previous chapter, we have shown that M3 receptor is required for optimal immunity against 
N.brasiliensis and acts as an important regulator of CD4 T cell function. However it still remains 
unclear whether a role for M3R is restricted to TH2 responses or is applicable to other classes of 
immune responses particularly the TH1 immune responses. To dissect the involvement of M3R in 
TH1 responses we used a bacterial pathogen Salmonella enterica sp. Typhimurium (referred to from 
now as S.typhimurium). S.typhimurium is a Gram negative bacterium that causes non-typhoidal 
salmonellosis (NTS); a disease characterized by diarrheal gastroenteritis in immunocompetent adult 
humans but in small children and HIV infected individuals results in system infection (invasive) 
NTS that has high mortality rates of between 22% and 47% (Gordon, Banda et al. 2002; Morpeth, 
Ramadhani et al. 2009; MacLennan, Gilchrist et al. 2010).  
 
S.typhimurium is a well established model in mice to study the progression of NTS and the associated 
immune response (Santos, Zhang et al. 2001; Mastroeni and Sheppard 2004). However in order to 
mimic disease progression in mice to that seen in humans as well as to study the adaptive immune 
response we use attenuated strains of Salmonella as wildtype strains are lethal, causing severe 
infection and death in mice within 10 days (O'Callaghan, Maskell et al. 1988). Therefore for this 
study we used the aroA SL3261 strain (Hoiseth and Stocker 1981) that has a well-defined kinetics of 
progression and immunocompetent mice are able to clear the infection within 35 days (O'Callaghan, 


















S.typhimurium induces a robust TH1 immune response that is essential for bacterial clearance 
(Mittrucker and Kaufmann 2000) with CD4 T cells and IFN-γ being critical in protection and 
bacterial clearance (Hess, Ladel et al. 1996). As muscarinic receptor regulation of TH1 immune 
response has not been well studied, S.typhimurium is a good model to employ in order to address this 
question. Previous studies have shown that administration of the non-subtype selective muscarinic 
receptor antagonist, atropine in vivo inhibits turpentine induced inflammation suggesting a pro-
inflammatory role for muscarinic receptors (Razani-Boroujerdi, Behl et al. 2008). In vitro, artificially 
skewing naïve CD4 T cells to the TH1 phenotype reduces expression of M3R at the mRNA and 
protein level providing further evidence that this receptor may be involved in regulating TH1 
immune responses (Qian, Galitovskiy et al. 2011). However, there is no conclusive evidence of 
immune system regulation by muscarinic receptor in general and M3R in particular  
 
In this chapter, we will examine the effect of M3R on development of TH1 immune response to a 
bacterial pathogen S.typhimurium by comparing kinetics of disease progression in wildtype and M3R-/- 





















2.1. M3 receptor is required for effective in vivo clearance of S.typhimurium. 
To determine the role of M3R during a primary bacterial infection, WT and M3R-/- mice were 
infected with 5 X 105 S.typhimurium bacteria i.p and killed at day 7, 18, 27 and 35 post-infection. 
S.typhimurium infection is lethal in mice but a genetic modification introduced into the aroA gene 
significantly attenuates its virulence and normal wildtype mice are capable of resolving the infection 
(Hoiseth and Stocker 1981). In our model, by day 35 WT mice had significantly reduced bacterial 
burden with most mice having less than 500 bacteria in the spleen (Fig 3.1A). The greatest reduction 
in bacterial burden (100 fold) occurred between day 18 and day 27 where the adaptive immune 
system and particularly CD4 T cells are known to play an important role in clearance.  M3R-/- mice 
were more susceptible to S.typhiumurium infection with a higher bacterial burden at day 18 (3-fold), 
27 (20-fold) and 35 (5-fold). This increased susceptibility is also evident from weight loss where WT 
mice suffer 5% drop in body weight at day 1 post-infection but quickly recover by day 4 however 
M3R-/- have a peak weight loss of 16% of body weight and only recover 25 days post-infection (Fig 
3.1B) Interestingly, bacterial burdens in WT and M3R-/- were similar during the early stages of the 
infection when the innate immune system is dominant (Kirby, Yrlid et al. 2002), however during the 
latter adaptive immune phase beginning from week 2 (McSorley, Cookson et al. 2000), a striking 
difference in bacterial burden is evident. A characteristic feature of S.typhimurium infection in murine 
hosts is marked splenomegaly (Jackson, Nanton et al. 2010) which is also observed in humans with 
nontyphoidal salmonella (Morpeth, Ramadhani et al. 2009). Spleens of M3R-/- mice were 
significantly smaller compared to WT mice post-infection (Fig 3.1C) however when we determined 
relative splenomegaly (=Spleen weight post-infection/Average pre-infection spleen weight), both 


















at day 18 post-infection (Fig 3.1D). Therefore, in the absence of M3R, mice are more susceptible to 
infection with an attenuated strain of S.typhimurium as evidenced by increased splenic bacterial 





Fig 3.1. M3R-/- mice are more susceptible to Salmonella typhimurium AroA infection compared to WT 
Balb/c mice. (A) Mice were infected with 8X105 CFU of an attenuated strain of S.typhimurium aroA i.p and 
monitored for 35 days post-infection. (B) Mice were weighed to determine changes in body weight after 
infection with S.typhimurium upto day 35 post-infection. (C) Spleens were weighed individually (D) Splenomegaly 
was determined as fold change over average spleen weight of naïve mice. Data are shown as mean ± SEM and 
is representative of 2-3 independent experiments with 6 mice in each group. Statistical significance was 




















2.2. M3R is required for optimal immune response and IFN-γ production during 
primary infection with S.typhimurium. 
In the absence of M3R, mice are more susceptible to infection with S.typhimurium aroA. To 
determine whether this increase in susceptibility had an underlying immunological basis, we 
examined the kinetics of key immune cell populations and production of the pro-inflammatory 
cytokine IFN-γ.  Overall, as the infection progressed there was a steady increase in total splenic 
cellularity upto day 18, after which it decreased to levels similar to that of naïve mice by day 35 and 
this kinetic was not disrupted in M3R-/- mice (Fig 3.2A). This increase in cellularity has also been 
observed in C57BL/6 mice infected with another attenuated strain of S.typhimurium (Jackson, 
Nanton et al. 2010). Total CD4 T cell numbers did not increase dramatically after infection, with 
peak numbers observed at day 27 where CD4 T cells were two-fold higher compared to naïve mice. 
There was a trend towards higher CD4 T cell numbers in M3R-/- mice however this did not reach 
statistical significance (Fig 3.2B). CD19+B220+ B cells remain constant upto day 18 post-infection 
in both WT and M3R-/- mice. However at day 27, there is a greater than 2 fold increase in the total 
number of B cells in WT mice but this was not observed for M3R-/- mice (Fig 3.2C). Germinal 
center (GC) formation is delayed in S.typhimurium infection, only appearing when bacterial burdens 
are reduced (Cunningham, Gaspal et al. 2007). Therefore, the increase in B cells in WT but not 
M3R-/- mice is possibly a result of the failure of M3R-/- mice to clear bacteria effectively and hence a 
further delay in GC formation.  
Macrophages are recruited rapidly to the spleen following infection and by day 7 are significantly 
higher (6 fold) compared to naïve mice. The number of macrophages in the spleen correlated to 
bacterial burden and returned to base line levels by day 35 when infection was resolved. M3R-/- mice 
had a significantly greater number of macrophages in the spleen compared to WT mice at day 18, 


















important role both as a host cell (Ibarra and Steele-Mortimer 2009) for S.typhimurium as well as 
effector cells when activated by CD4 T cell derived IFN-γ (VanCott, Chatfield et al. 1998). Since 
IFN-γ is critical for protection and clearance of S.typhimurium (Hess, Ladel et al. 1996), we measured 
this cytokine in supernatants from anti-CD3 restimulated splenocytes. Highest amounts of IFN-γ 
are produced early after infection at day 7 by innate immune cells such as Natural Killer (NK) cells, 
neutrophils and macrophages (Ramarathinam, Niesel et al. 1993; Kirby, Yrlid et al. 2002). However, 
by day 18 and 27 IFN-γ production by M3R-/- splenocytes is markedly reduced (Fig 3.2E). This 
decrease in IFN-γ synthesis may be the key mechanism driving enhanced susceptibility of M3R-/- 




















Fig 3.2. M3R is required for optimal immune response and IFN-γ production during primary infection 
with S.typhimurium. (A) Total spleen cellularity was determined at different time points. Splenocytes were then 
analysed by flow cytometry using surface markers for different immune cells and number of cells were calculated 
for (B) CD3+CD4+ T cells (C) CD19+B220+ B cells (D) CD11b+F4/80+ splenic macrophages. (E) 1 X106 
splenocytes per well from WT and M3R-/- mice were stimulated with heat-killed S.typhimurium for 24 hours and 
IFN-γ was measured in the supernatants by ELISA. . Data are shown as mean ± SEM and is representative of 2-3 
independent experiments with 6 mice in each group. Statistical significance was calculated using Two-way ANOVA 




















2.3. M3R does not affect memory immune response to S.typhimurium after 
vaccination with heat-killed bacteria. 
We have shown previously that in the absence of M3R both primary and memory immune 
responses to N.brasiliensis are diminished and M3R-/- mice also have delayed clearance of a primary 
S.typhimurium infection. We therefore wanted to investigate the effect of M3R deletion on memory 
immune response to S.typhimurium. WT and M3R-/- mice were vaccinated with 1 X107 CFU of heat-
killed S.typhimurium aroA, rested for 4 weeks after which the mice were re-infected with 1 x 106 live 
aroA bacteria and killed on day 7 post infection. Heat-killed Salmonella has been shown to elicit 
protective responses in mice when used as a vaccination against a lethal S.typhimurium strain. 
Vaccination of wildtype mice with heat-killed bacteria results in protection with bacterial burdens 
reduced 500 fold compared to unvaccinated mice (Fig3.3A). Interestingly, M3R-/- mice also have a 
similar level of protection after vaccination (WT – 6350 bacteria/spleen; M3R-/- - 6324 
bacteria/spleen – Fig 3.3A) indicating that memory immune response at least against an attenuated 
strain of S.typhimurium is not dependent on M3R.Splenocytes from vaccinated mice secrete 
significantly lower amounts of IFN-γ which correlated with the lower bacterial burden at day 7 post-
infection however there was no difference between WT and M3R-/- vaccinated mice (Fig 3.3B). 
Vaccinated M3R-/- mice had a higher proportion of B cells (WT- 9.35% M3R-/--11.8%) and a similar 
proportion of total CD4 T cells. However M3R-/- mice had a significantly lower proportion of 
activated CD4 T cells (WT – 4.7% M3R-/-- 2.5%) as measured by the expression of CD44hi and 
CD62Llo(Fig3.3C). Therefore we can conclude that deletion of M3R does not affect vaccination 
induced protection against S.typhimurium. Vaccinated WT mice also have a higher proportion of 
activated CD4 T cells (2-fold) compared to M3R-/- mice however this does not translate to IFN-γ 




















  Fig 3.3 M3R is not required for memory immune response to S.typhimurium after vaccination with heat-
killed bacteria. Mice were vaccinated with 1 X107 heat-killed S.typhimurium aroA, rested for 4 weeks and re-
infected with 1 x 106 live aroA bacteria. (A) Spleen bacterial burden was determined at day 7 post-secondary 
infection (B) 1 x 106 splenocytes were restimulated with heat-killed bacteria for 72 hours and IFN-γ levels were 
measured by ELISA. (C) Flow cytometry was used to determine the proportion of B cells (CD19+), CD4 T cells 
(CD3+CD4+) and activated CD4 T cells (CD3+CD4+CD44hiCD62Llo). Data are shown as mean ± SEM and is 
representative of two independent experiments with 5 mice in each group. Statistical significance was calculated 



















2.4. M3R deficient macrophages are effective at bacterial killing in vitro. 
Protective immunity against S.typhimurium is highly dependent on phagocytosis and intracellular 
killing by macrophages (Lindgren, Stojiljkovic et al. 1996). To determine whether the susceptibility 
of M3R-/- mice is due to a defect in the bactericidal capacity of macrophages, an in vitro pathogen kill 
assay using bone marrow derived macrophages (BMDM) was setup. BMDMs, generated from WT 
and M3R-/- mice, were infected with S.typhimurium aroA at a multiplicity of infection (MOI) of 2 and 
10 either in the presence or absence of 100ng/ml IFN-γ for activation. Bactericidal activity was 
determined by counting the number of viable colony forming bacteria remaining at various time 
points upto 24 hours post-infection. WT and M3R-/- macrophages were both capable of killing 
S.typhimurium aroA in vitro when added at an MOI of 2 or 10 and there was no difference in 
bactericidal capacity in the absence of M3R (Fig 3.4). Furthermore, overnight treatment with 
100ng/ml IFN-γ did not improve the bactericidal capacity of macrophages against S.typhimurium. We 
can conclude that M3R deficiency on macrophages does not affect its bactericidal capacity and thus 























Fig 3.4: WT and M3R-/- bone marrow derived macrophages have similar bactericidal capacity in vitro. 
BMDMs were generated from WT and M3R-/- , plated at 5X105 cells/well in 24 well plates  and either left 
unstimulated or stimulated with 100ng/ml IFN-g overnight to activate them. S.typhimurium AroA was added at 
MOI of 2 or 10 and bacterial burden was followed over a period of 24 hours by plating colony plating on LB 



















2.5. M3R expression on B lymphocytes is not required for immunity against 
S.typhimurium. 
Igμ-/- mice (μMT) are totally devoid of B cells but are still able to clear an infection with attenuated 
S.typhimurium (aroA) similarly to wildtype mice thus implying that B cells might not be important 
atleast for a primary infection with an attenuated strain (Mittrucker, Raupach et al. 2000). However, 
B cells are important in vaccination induced protective immunity to lethal S.typhimurium infection by 
enhancing T cell mediated immunity independent of its ability to produce antibody (Nanton, Way et 
al. 2012). Furthermore, specific antibodies also reduce the extracellular spread of S.typhimurium and 
its colonization of splenic macrophages (Cunningham, Gaspal et al. 2007) and can also provide 
protection aginast lethal strains (McSorley and Jenkins 2000). We have shown that M3R-/- mice have 
lower B cell numbers at day 27 in the spleen following S.typhimurium infection. To determine 
whether B cell M3R expression plays a role in bacterial clearance, we generated a bone marrow 
chimera where only B cells did not express M3R (refer Materials and Method). B cell repopulation of 
recipient mice was checked 6 weeks after bone marrow transfer in the blood. Irradiated μMT mice 
receiving WT and M3R-/- bone marrow had detectable levels of B cells in the blood compared to 
normal μMT thus confirming the chimeras were successful (Fig 3.5A). Mice were then infected with 
1X 106 bacteria per mouse and killed at day 27 post-infection. As expected from previous results, 
normal M3R-/- had a greater than 10 fold higher bacterial burden to normal WT mice. However, no 
significant difference in bacterial burden was observed between WT and B cell-M3R-/- chimeric mice 
and therefore concluding that M3R on B cells does not contribute to S.typhimurium aroA clearance 
(Fig 3.5B). Both chimeric mice had a higher bacterial burden than un-irradiated μMT mice which 
may be due to toxic effects of radiation on other immune cells. M3R expression on B cells also does 
not affect antigen specific antibody production as both WT and B cell-M3R-/- chimeras had similar 


















mice were also able to confer equivalent protection to naïve mice in vivo after opsonization of 
S.typhimurium aroA (Fig 3.5E) indicating that both the quantity and quality of Salmonella specific 
antibodies are not affected after M3R deletion on B cells.  
An interesting observation was made regarding number of B cells in the two chimeras. B cell-M3R-/- 
chimera mice had significantly more B cells (2-fold) in the blood prior to infection compared to WT 
chimeras. This was also observed in splenic B cell populations at day 27 post infection where B cell 
numbers were 4-fold higher in B cell-M3R-/- chimeras (Fig 3.5B). This data suggests that in the 
absence of M3R, there is increased proliferation relative to M3R sufficient cells as evidenced by the 






















  Fig 3.5 Deletion of M3R on B cells only does not contribute to increased susceptibility to S.typhimurium. B cell 
specific deletion of M3R was obtained by mixed bone marrow chimeras where B cell deficient uMT mice were irradiated 
and reconstituted with bone marrow (BM) made up of 80% uMT BM and 20% of either WT (BM WT) or M3R-/- bone 
marrow (BM M3R-/-). (A) After resting for 6 weeks, B cell reconstitution of BM chimeras was checked in blood (B) Mice 
were infected with 1 X 106 aroA bacteria and spleen bacterial burden determined on day 27 post-infection. (C) B cell 
numbers were determined in the spleen at day 27 using the markers CD19 and B220. (D) Production of Salmonella specific 
IgG1 and IgG2a antibodies was determined in BM chimeras at day 27 using ELISA. (E) Effectiveness of antibodies 
produced by WT or M3R-/- B cells was tested in vivo by opsonization. Serum from WT and M3R-/- B cell specific bone 
marrow chimeras was heated at 65oC for 30 mins to inactivate complement and incubated with 2.5 X 106 bacteria/ml at 
10% serum concentration for 30 mins at room temperature. Naïve BALB/c mice were infected with opsonized 
S.typhimurium aroA and killed after 5 days and spleen bacterial burden enumerated. Data are shown as mean ± SEM and 
is representative of one independent experiments with 6 mice in each group. Statistical significance was calculated using 



















2.6. CD4 T cells from M3R-/- mice have reduced activation and CD28 expression in 
vivo after S.typhimurium infection.  
CD4 T cells are essential for mounting an effective immune response to S.typhimurium and in nude 
athymic mice which lack CD4 T cells, attenuated strains of S.typhimurium including aroA are lethal 
(Coynault and Norel 1999). We have shown that in a TH2 biased immune response to N.brasiliensis, 
M3R expression on CD4 T cells enhances expulsion of the nematode parasite in a primary infection. 
Therefore we set out to determine whether CD4 T cell function is also influenced by M3R during a 
TH1-dominant immune response induced by S.typhimurium.  
At the transcript level, M3R expression was reduced by more than 2-fold at day 18 and 27 following 
S.typhimurium infection (Fig 3.6A), which differs from the 3-fold increase observed after infection 
with N.brasiliensis. Activation of splenic CD4 T cells, as determined by expression of the marker 
CD62L (CD3+CD4+CD62Llo), was severely impaired in M3R-/- mice at day 18 where 21% of its 
CD4 T cells were activated compared to 36% for WT mice (Fig 3.6B). Despite bacterial burdens 
being similar in WT and M3R-/- mice at day 18, this difference in activation of T cells may account 
for the large (100 fold) difference in bacterial burdens observed at later time points (day 27). By day 
27, the percentage of activated CD4 T cells in the M3R-/- mice increases to the same level as in WT 
mice (35.8% - WT and 33.2% - M3R-/-). Interestingly, reduced CD4 T cell activation in M3R-/- mice 
at day 18 was correlated with a significant decrease in expression of the co-stimulatory marker CD28 
on the CD4 T cells (Fig 3.6C). Reduced CD28 expression was also observed after N.brasiliensis 





















  Fig 3.6: M3R transcription is regulated in CD4 T cells after S.typhimurium infection and CD4 T cells from M3R-/- mice 
have a reduced CD4 T cell activation status at day 18 post-infection. (A) Real time quantification of the M3 receptor transcript 
(CHRM3) in CD4 T cells sorted by flow cytomtery from the spleen of infected WT and M3R-/- mice at day 18 and 27 p.i. 
(B)Splenocytes at day 18 and day 27 were stained with the following cell surface markers CD3, CD4, CD62L and CD28 to 
determine proportion of activated CD4 T cells denoted by CD3+CD4+CD62Llo  and (C) expression of the costimulatory marker 
CD28. Data are shown as mean ± SEM and is representative of two independent experiments with 6 mice in each group. Statistical 




















2.7. CD4 T cells from M3R-/- mice have reduced expression of the TH1 transcription 
factor T-bet correlated with reduced pro-inflammatory cytokine production. 
To further probe the effect of M3R deletion on CD4 T cell function after infection with 
S.typhimurium, we determined expression levels of two pro-inflammatory cytokines Interferon-
gamma (IFN-γ) and Tumour Necrosis Factor alpha (TNF-α) as well as the TH1 inducing 
transcription factor T-box expressed in T cells (T-bet) (Szabo, Kim et al. 2000) at the mRNA level. IFN-
γ production by CD4 T cells at the mRNA level was greatly increased (110-fold) at day 18 post-
infection suggesting that this is one of the main features of CD4 T cell activation after S.typhimurium 
infection. M3R-/- CD4 T cells in contrast had a significantly lower IFN-γ production (30-fold 
compared to WT uninfected) (Fig 3.7A) which correlates with its lower activation status. By day 27 
IFN-g levels returned to almost base-line levels suggesting that CD4 T cell-mediated production of 
IFN-γ occurred mainly between d18 and d27. This period also correlates with a significant decrease 
(100-fold) in spleen bacterial burden (Fig 3.1A). IFN-γ is produced by a number of cell types after 
infection, with natural killer (NK) cells being an important early source (Schafer and Eisenstein 
1992) while during the later stages of infection this role is taken up by Salmonella specific TH1 CD4 T 
cells. IFN-γ is essential for control of S.typhimurium infection, and infection with an attenuated strain 
is lethal in IFN-γR-/- mice highlighting the importance of this cytokine (Hess, Ladel et al. 1996). 
Another pro-inflammatory cytokine, TNF-α was also reduced in M3R-/- CD4 T cells but to a lesser 
extent compared to IFN-γ (Fig 3.7A). We also observed a significantly lower infection-induced 
enhancement in T-bet mRNA synthesis in the absence of M3R (44-fold in WT versus 15-fold in 
M3R-/-) (Fig 3.7B). Since differentiation of naïve T cells into the TH1 lineage and synthesis of IFN-γ 
is controlled by the transcription factor T-bet (Szabo, Kim et al. 2000), the reduced IFN-γ 
production in the absence of M3R likely results from a defect at step prior to increase in 


















mice do not generate IFN-γ producing CD4 T cells and succumb to infection (Ravindran, Foley et 
al. 2005). Decrease IFN-g at the mRNA level also translated into decreased IFN-γ production at the 
protein level. M3R-/- mice had a 2 fold lower proportion and number of IFN-γ+ CD4 T cells in the 
spleen at day 18 (Fig 3.7C). A very small percentage of CD4 T cells were positive for TNF-α, and 
therefore it was difficult to determine whether the secretion of this cytokine was also reduced. The 
decrease in IFN-γ was specific for CD4 T cells, as the CD4 negative population had similar levels of 
IFN-γ producing cells in the WT and M3R-/- mice (Fig 3.7D). The non-CD4 T cell population had a 





















Fig 3.7: M3R-/- CD4 T cells have reduced levels of the TH1 transcription factor Tbet which correlates with decreased 
CD4 T cell IFN-γ production at day 18 post-infection. Splenic CD4 T cells were purified using flow cytometry to greater than 
99% purity and RNA was extracted using the Qiagen Mini RNA kit. RNA was reverse transcribed to cDNA and real time PCR 
(ΔΔCT method) used to determine levels of (A) Pro-inflammatory cytokines IFN-γ and TNF-α as well as (B) the TH1 specific 
transcription factor Tbet. All genes were normalized to the housekeeping gene HPRT and the fold change was calculated relative 
to WT CD4 T cells from uninfected mice. Splenocytes from mice at day 18 post infection were stimulated with heat-killed 
S.typhimurium for 24 hours with monensin added in the last 4 hours to block cytokine secretion. Cells were first stained with CD3 
and CD4, after which the cells were fixed, permeabilized and stained with IFN-γ and TNF-α to detect cytokine secretion in (C) 
CD4+ T cells and (D) CD4neg splenocyte populations. Data are shown as mean ± SEM and is from one independent experiment 
with 5-6 mice in each group. Statistical significance was calculated using the Mann-Whitney two-tailed t test and denoted by * 




















3. Discussion:  
In this chapter we investigate whether M3R regulates the T helper type 1 response, launched as a 
protective response to a bacterial infection. This added a new dimension to our previous data which 
demonstrated that M3R enhance TH2 responses and thus attribute a broader role for the M3R in 
regulating two fundamentally different classes of immune response launched against a bacterial and 
helminth pathogen.  
We used an attenuated strain of the bacterial pathogen Salmonella typhimurium aroA, which can 
naturally be cleared by wildtype mice after a robust CD4 T cell mediated TH1 response. As expected 
wildtype mice were able to clear S.typhimurium aroA gradually over 5 weeks. In contrast, M3R-/- mice 
are more susceptible to infection, with significantly higher bacterial burden beginning on day 18 
post-infection up to the end of the infection period. This increased susceptibility was also evident 
from the significantly higher weight loss in the M3R-/- mice which had lost almost 20% of their body 
weight while WT mice had recovered. A number of studies exist that highlight involvement of 
cholinergic signaling either via acetylcholine or one of its receptors in bacterial infection. In vivo 
inhibition of acetylcholinesterase using a chemical inhibitor which raises acetylcholine levels 
significantly improved survival after lethal S.typhimurium infection and increased serum IL-12p40 
implying a possible pro-inflammatory role for increased acetylcholine (Fernandez-Cabezudo, Lorke 
et al. 2010). With respect to acetylcholine receptor involvement in bacterial infection, nicotinic 
receptor deficient mice (nα7AChR-/-) have improved control of Escherichia coli burden after an 
intraperitoneal infection indicating that nicotinic receptors, via their anti-inflammatory property, 
inhibit bacterial clearance (Giebelen, Le Moine et al. 2008). However, our study is the first 
demonstration of muscarinic receptor involvement in optimal control of bacterial infection possibly 


















We further investigated the effect of M3R deletion on the kinetics of immune cell recruitment 
and/or development in the spleen after infection with S.typhimurium. While CD4 T cell numbers 
were similar in WT and M3R-/- mice, the numbers of B cells and macrophages differed significantly 
at various times after infection. B cells were increased after germinal center formation in WT mice 
(Cunningham, Gaspal et al. 2007) but this was not observed in M3R-/- mice. There were also 
significantly more macrophages in the spleens of M3R-/- mice at day 18 possibly as a result of 
increased bacterial burden. Macrophages are activated by IFN-γ from a variety of sources such as 
NK cells and neutrophils early in the infection and CD4 T cells during the adaptive phase 
(Ramarathinam, Niesel et al. 1993; Ravindran, Foley et al. 2005) in order to effectively kill 
intracellular S.typhimurium. Splenocytes from M3R-/- mice produced less IFN-γ compared to 
wildtype mice particularly in the adaptive phase of the immune system. Due to the central role 
played by IFN-γ, this defect could account for the increased susceptibility in the absence of M3R. 
We then probed the functional role of M3R in each of these immune cell populations using various 
techniques such as bone marrow chimeras, in vitro bactericidal activities and isolation of target cells. 
Macrophages readily phagocytose S.tyhpimurium , playing an important role in bacterial clearance in 
vivo (Mastroeni 2002) and are also capable of killing various strains including the aroA strain  in vitro 
(Fields, Swanson et al. 1986). We found that M3R-/- deficient bone marrow derived macrophages 
were able to kill S.typhimurium aroA similarly to wildtype macrophages and thus a defect in 
macrophage bactericidal activity does not account for increased susceptibility of the M3R-/- mice. 
However, even though we demonstrate that ex vivo generated M3R-/- macrophages may be efficient 
in killing Salmonella, we cannot rule out that splenic macrophages in M3R-/- mice may have a reduced 
bactericidal capacity as a result of interaction with its environment consisting of other immune cells 


















We also generated a mouse strain with a B cell specific deletion of M3R using bone marrow 
chimeras to determine the M3R dependent contribution of this immune cell type. B cells are 
required for optimal control of a primary lethal S.typhimurium infection as well as memory induced 
protection after vaccination (Mittrucker, Raupach et al. 2000). B cell deficient mice are capable of 
clearing attenuated aroA- S.typhimurium strain effectively (Mittrucker, Raupach et al. 2000); however 
B cells have been shown to impair protective immune response by producing IL-10 in a Myd88 
dependent manner even after infection with attenuated S.typhimurium strains (Neves, Lampropoulou 
et al. 2010). We showed that mice which selectively lacked M3R only on B cells were capable of 
capable of clearing S.typhimurium similarly to BM chimeras with normal B cells suggesting this 
immune cell type is not involved in driving susceptibility in M3R-/- mice. We did however find that B 
cell specific M3R-/- mice had increased numbers of B cells in the blood (2-fold) prior to infection as 
well as in the spleen (4 fold) post-infection. This highlights a potential role for M3R in regulating cell 
proliferation or cell death, an area for future investigation. Indeed M3R has been previously 
implicated in regulating proliferation in a number of cancer cells particularly colon cancer lines 
(Raufman, Samimi et al. 2008) as well as apoptosis (Budd, Spragg et al. 2004).  
Finally, we examined CD4 T cell function in M3R-/- mice following S.typhimurium aroA infection as 
CD4 T cells are critical for protection and bacterial clearance and attenuated S.typhimurium is lethal in 
mice lacking CD4 T cells (Hess, Ladel et al. 1996). During peak of T cell response in this mice (day 
18) (Srinivasan, Foley et al. 2004), M3R expression is significantly reduced in CD4 T cells by 60% 
compared to pre-infection levels which agrees with previously published data on in vitro generated 
TH1 CD4 T cells (Qian, Galitovskiy et al. 2011). CD4 T cell activation at day 18 is markedly reduced 
in M3R-/- mice correlated to the increased bacterial burden observed at this time point and although 


















level to wildtype mice. Similarly CD28 expression on M3R-/- CD4 T cells is significantly lower at day 
18 but not at day 27 post-infection. This pattern is remarkably similar to that observed during 
Nippostrongylus brasiliensis infection indicating that M3R regulates CD4 T cell activation and CD28 
expression in both TH1 and TH2 skewed disease models. CD28 is essential for immunity against 
S.typhimurium, and CD28-/- mice are highly susceptible even to the attenuated aroA- strain 
(Mittrucker, Kohler et al. 1999). CD28 is important for development of a TH1 response particularly 
IFN-g production (Lenschow, Walunas et al. 1996) and this was postulated as the main mechanism 
for the observed increase in susceptibility of CD28-/- mice to S.typhimurium (Mittrucker, Kohler et al. 
1999), further supported by the fact that IFN-γR-/- mice are similarly highly susceptible to 
S.typhimurium (Hess, Ladel et al. 1996). In the M3R-/- mice, we also observed a decrease in IFN-γ 
mRNA levels in CD4 T cells as well as the number of IFN-γ secreting CD4 T cells in the spleen 
after an S.typhimurium infection, suggesting that a similar mechanism of CD28 costimulation driven 
IFN-γ production by CD4 T cells is responsible for the increased susceptibility. Interestingly, IFN- 
secretion by non-CD4 T cells was not affected, providing further evidence that M3R mainly 
influences CD4 T cell function. Mice lacking the muscarinic receptors M1 and M5 (M1R-/-M5R-/-) 
also have reduced production of pro-inflammatory cytokines IFN-γ and TNF-α after ovalbumin 
immunization (Kawashima, Fujii et al. 2012), demonstrating that other muscarinic subtypes may also 
be involved in modulating pro-inflammatory immune responses. Furthermore a key question still 
remains whether M3R directly regulates CD28 expression and function or acts indirectly via other 
receptors and/or proteins and if other muscarinic receptor subtypes such as M1 and M5 may act in 
synergy to enhance immune responses. The latter question can be answered by generating triple 
knockout mice lacking all 3 muscarinic subtypes (M1, M3 and M5) that have a similar mechanism of 


















This chapter provides the first comprehensive characterization of a bacterial infection in the M3R-/- 
mice and identifies an important role for the M3 muscarinic receptor in generation of an effective 
TH1 immune response. We also determined that M3R
-/- CD4 T cells, but not B cells or 
macrophages, have markedly reduced T-bet mediated IFN- production and CD28 expression 
which strongly correlated with higher bacterial burdens and increased susceptibility to infection. This 
study also supports previously published literature that muscarinic receptors are pro-inflammatory 
(Razani-Boroujerdi, Behl et al. 2008; Oenema, Kolahian et al. 2010), and further also provides more 
conclusive data using receptor deficient mice, muscarinic agonists and two fu damentally different 












































Cholinergic signaling is an important physiological pathway regulated by the neurotransmitter 
acetylcholine via its two receptor subtypes, nicotinic and muscarinic receptors (Albuquerque, Pereira 
et al. 2009). Classically known for its role in nerve impulse transmission (Picciotto, Higley et al. 
2012), the cholinergic system has now been described in numerous non-neuronal cells such as 
smooth muscle cells (Roffel, Elzinga et al. 1990), skin keratinocytes (Ndoye, Buchli et al. 1998), bone 
osteoclasts (En-Nosse, Hartmann et al. 2009) and immune cells (Kawashima, Fujii et al. 2012). Over 
the last decade, an increasing number of studies have described a significant role for acetylcholine in 
immunity, particularly the dampening of pro-inflammatory immune responses of macrophages by 
signaling via the 7 subunit of nicotinic receptors (Wang, Yu et al. 2003). This pathway, termed the 
Cholinergic Anti-inflammatory Pathway (CAP) (Tracey 2007), is regulated by acetylcholine secreted 
from a subset of activated CD4 T cells in the spleen (Rosas-Ballina, Olofsson et al. 2011). Other 
studies have characterized different aspects of the cholinergic system in immune cells such as 
expression of nicotinic and muscarinic receptors upon activation (Qian, Galitovskiy et al. 2011), the 
role for acetylcholinesterase in controlling inflammation (Shaked, Meerson et al. 2009) and nicotinic 
receptors in bacterial infections (Giebelen, Le Moine et al. 2008; Radek, Elias et al. 2010). However, 
despite conclusive evidence of cholinergic regulation of immunity and the key role played by 
nicotinic receptors, the role for muscarinic receptors which also exist on many of the same immune 
cells remains unknown. In this study, we showed that M3 muscarinic receptor also plays an 
important in regulating immunity, however unlike the nicotinic receptor which is anti-inflammatory 
(Caulfield and Birdsall 1998; Wang, Yu et al. 2003); the M3 muscarinic receptor enhances immune 
responses.  This finding is supported by published studies which ascribe a potential pro-
inflammatory function for muscarinic receptors. Administration of a non-subtype selective 


















inflammation induced by turpentine as well as antigen specific T and B cell responses to an inert 
antigen (Razani-Boroujerdi, Behl et al. 2008).  
 
Muscarinic receptor is a family of five subtypes (M1-M5) (Caulfield 1993) and in our study we 
identified the M3 subtype as the major receptor responsible for regulating immunity to pathogens 
using genetically engineered mouse strain lacking the M3 receptor (M3R-/-). In the absence of M3R, 
mice were more susceptible to two pathogens, the nematode parasite Nippostrongylus brasiliensis and 
the bacterium Salmonella enterica sp. Typhimurium. This increase in susceptibility was marked by 
increased pathogen burden and strongly correlated with a decrease in key immune responses such as 
production of cytokines IL-13 and IFN-γ which are essential for protection during N.brasiliensis and 
S.typhimurium infections respectively. Furthermore, stimulation of lymphocytes from N.brasiliensis 
infected mice with muscarinic agonists significantly enhanced production of IL-13, an effect that 
was not observed in M3R-/- lymphocytes. This provides a potential mechanism by which stimulation 
of M3R enhances immune responses. Other muscarinic receptor subtypes such as M1 and M5 have 
previously been suggested to regulate immunity by being required for development of CD8 T cells in 
vitro, however this effect was not observed in vivo (Vezys, Masopust et al. 2007). Our study is thus the 
first in vivo demonstration of a muscarinic receptor subtype involved in the regulation of immunity.  
 
M3 receptor is expressed on a number of immune cells such as macrophages, dendritic cells, B cells, 
CD4 and CD8 T cells in mice but has also been shown on human immune cells (Fujii and 
Kawashima 2000; Kawashima, Yoshikawa et al. 2007; Qian, Galitovskiy et al. 2011). We identified 
CD4 T cells as the key immune cell population affected in the absence of M3R. After N.brasiliensis 
and S.typhimurium infection, M3R was required for the optimal activation of CD4 T cells as the 


















significantly lower. Production of important cytokines IL-13 and IFN-γ by CD4 T cells was also 
significantly reduced at the mRNA and protein level. Interestingly, basal CD4 T cell activation in 
naïve mice prior to infection with the two pathogens was similar in the presence or absence of M3R. 
In the case of N.brasiliensis, protective immunity obtained by adoptive transfer of antigen 
experienced CD4 T cell was completely abrogated in the absence of M3R. This is a clear indication 
that M3R is required for an effective pathogen induced activation of CD4 T cells which have 
optimal cytokine production and capability for pathogen clearance.  
 
Our study indicates the M3R is required for optimal development of both TH1 and TH2 immunity 
and therefore may be acting at a stage prior to differentiation of the immune response. However, 
some differences do exist between TH1 and TH2 response particularly in relation to the expression of 
M3R at the messenger RNA level on CD4 T cells. After N.brasiliensis, infection when the immune 
environment is skewed towards a T helper 2 immune response, expression of M3R is increased CD4 
T cells whereas after S.typhimurium infection which induces a T helper 1 response M3R expression is 
decreased. Since TH1 responses are pro-inflammatory and cause significant tissue pathology if left 
uncontrolled (Rennick, Fort et al. 1997), decreased M3R expression on CD4 T cells may be a self-
regulatory mechanism to reduce production of cytokines such as IFN-γ. TH2 responses on the other 
hand help limit pro-inflammatory immune pathology during helminth infections (Hunter and 
McKay 2004; Dewals, Hoving et al. 2010) and therefore enhanced M3R expression which may result 
in cholinergic mediated increase in TH2 cytokine production will be beneficial to the hosts. 
 
The mechanism of action by which M3R controls the activation of CD4 T cells has not been 
conclusively identified. The classical route of T cell activation involved interaction between MHCII 


















(TCR) on CD4 T cells. A secondary costimulatory interaction between CD80/86 on APCs and 
CD28 on CD4 T cells is required to complete the activation signal (Lenschow, Walunas et al. 1996). 
We found that expression of CD28 on M3R-/- CD4 T cells was significantly lower compared to 
wildtype CD4 T cells in naïve mice as well as after N.brasiliensis and S.typhimurium infection. M3R 
control of CD28 expression either directly or indirectly may explain the reduced activation of CD4 
T cells in the absence of this receptor. The central role of CD28 in controlling pathogen infection is 
also highlighted by increased susceptibility of CD28-/- mice to N.brasiliensis and S.typhimurium 
infection (Mittrucker, Kohler et al. 1999). Therefore, M3R mediated decrease in CD28 expression 
may account for the increased susceptibility of the M3R-/- mice. Further work is required to verify 























Our study is the first conclusive demonstration of a role for muscarinic receptors in immunity. 
Using genetically engineered mouse strains and pathogen models, we have identified M3 muscarinic 
subtype as the main subtype required for enhancing protective immune response and clearance of 
two distinct pathogens, a nematode parasite N.brasiliensis and bacterial pathogen S.typhimurium. 
Cholinergic regulation of immunity is an important emerging paradigm and our study identifies a 
role for muscarinic receptors that will have potential benefits in improving immune responses to 
pathogens.  






















We have identified a key role for muscarinic receptor in regulating immunity, raising interesting 
questions that will be the focus of future research. Firstly, we need to determine whether immune 
regulatory function of M3R is also observed in human immune cells. Given the highly conserved 
nature of the M3R (92% similarity between human and murine M3R), it is highly likely that this 
function is also conserved. To confirm this we will measure cytokine production after restimulation 
of peripheral blood mononuclear cells (PBMCs) in the presence of muscarinic agonists and 
antagonists to determine whether muscarinic stimulation enhances cytokine production similarly to 
the murine model. Modest reductions in IL--5 and IL-13 production after tiotropium treatment of 
phytohemagluttinin (PHA) stimulated PBMCs has been reported supporting the theory that M3 
receptors behave similarly in human cells (Ohta, Oda et al. 2010). We will examine antigen specific 
responses particularly after vaccination and in bronchoaveolar lavage (BAL) cells of people that 
regularly inhale tiotropium for relieving asthma. 
 
Secondly, we found that M3R regulate CD4 T cell function possibly via regulating expression of the 
co-stimulatory receptor CD28. It still remains to be determined whether there is a direct correlation 
between M3R and CD28. A second potential mechanism by which M3R can affect CD4 T cell 
function is by regulating intracellular calcium (Ca2+) levels. M3R binding of its agonists such as 
acetylcholine results in influx of Ca2+ ions into the cytosol (Caulfield 1993). This influx is also a 
characteristic feature of CD4 T cell activation (Lewis 2001) and therefore it remains to be 




















Of the muscarinic subtypes, the M3R is targeted by a number of antagonistic drugs for relieving 
symptoms of aberrant smooth muscle contraction in overactive bladder disorder such as darifenacin 
and asthma and chronic obstructive pulmonary disease (COPD) such as tiotropium bromide (Wess, 
Eglen et al. 2007). Findings from our study raise important concerns about unintended 
consequences of the potential immune modulating properties of M3R antagonists. On the one hand, 
this may be beneficial as treatment of asthma related bronchoconstriction using tiotropium 
(Casaburi, Mahler et al. 2002; Kerstjens, Engel et al. 2012) may have the additional benefit of 
inhibiting TH2 responses that cause other pathological features of asthma such as IL-13 dependent 
IgE production and mucus hypersecretion in the lungs (Barnes 2008). This has already been shown 
in mice, where tiotropium inhalation treatment of mice with ovalbumin induced allergy resulted in a 
significant reduction in TH2 immune responses (Ohta, Oda et al. 2010). However on the other hand, 
we show that M3R is also required for an effective pro-inflammatory TH1 response. Therefore, 
blocking M3R using tiotropium in the lung may enhance susceptibility of the users to common viral 
and bacterial infections of the lung such as influenza, TB and pneumonia as these require TH1 
responses for control (Kadioglu and Andrew 2004; Doherty and Andersen 2005; Forrest, Pride et al. 
2008). Hence in light of our findings, future studies of M3R antagonists used as therapeutic drugs 
must also consider the immunomodulatory side effects of muscarinic receptor blocking. 
Additionally, M3R antagonists may also be used to exploit the immune enhancing property of the 
M3R, and therefore we need to determine whether administration of approved M3R antagonist 
drugs in vivo can help suppress cytokine production in conditions where excessive pro-inflammation 
is detrimental. Conversely, it will be interesting to determine whether immune responses during a 
natural infection or after vaccination can be enhanced by administering muscarinic agonists. The 
crystal structure of M3R has recently been solved (Kruse, Hu et al. 2012) and will further aid the 


















during in vivo immune modulation. Regulation of immunity by muscarinic receptors represents an 
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1.2 ml Anaket V (Ketamine) 
0.8 ml 2% Rompun (Xylazine) 
8 ml 1X PBS 
ELISA Blocking Buffer: 
20 g Milk Powder 
1000 ml 1X PBS 
ELISA Dilution Buffer: 
10g Bovine Serum Albumin (BSA) 
1X PBS 
ELISA Substrate Buffer (For Alkaline Phosphatase assay): 
0.2 g NaN3 
97 ml di-ethanolamine 
0.8 g MgCl2.6H2O 
700 ml ddH2O 
Adjust pH to 9.8 and make up to final volume of 1L using ddH2O 



















ELISA Washing Buffer 
20 g KCl   800 g NaCl 
50 ml Tween-20   144 g Na2HPO4.H2O 
20 g KH2PO4 
Make up to 5 L with ddH2O 
Flow Cytometry Buffer: 
1 g BSA (0.1% BSA) 
Make up to 1L with 1X PBS and filter sterilize. Store at 40C 
Iscove’s Modified Dulbecco’s Medium (IMDM) (Gibco): 
Full composition available from Gibco – Invitrogen Product number: 12440-053 
Contains Phenol Red (0.04mM), D-Glucose (25mM), HEPES (25mM) 
Luria Broth medium for S.typhimurium ΔaroA 
10 g Tryptic Soy powder 
5 g Yeast extract 
10 g NaCl 
Make up to 1L with ddH2O, autoclave at 1210C for 10 mins and store at 40C 
For agar, add 12 g of bacterial grade agar to 1L of LB medium before autoclaving. 
1X Phosphate Buffered Saline (PBS): 
8 g NaCl   1.44g NaH2PO4 
0.2 g KCl   0.24 g KH2PO4 



















10% Inactivated fetal calf serum 
5% Inactivated horse serum 
30% L929 conditioned medium (source of Macrophage Colony stimulating factor – M-CSF) 
50U/ml Penicillin/Streptomycin 
2 mM L-glutamine 
1 mM Na-Pyruvate 
50 μM -Mercaptoethanol 
Make upto a final volume of 500mls using DMEM medium. Filter sterilize and store at 40C. 
Red Cell Lysis Buffer 
8.26 g NH4Cl 
1 g KHCO3 
0.037 g EDTA 
Make up to 1L with ddH2O, adjust pH to 7.4 and autoclave at 121
0C for 10 mins to sterilize. 
Tissue Lysis Buffer: 
5mM EDTA     10% Glycerol 
0.1% Sodium dodecylsulphate (SDS)  0.5% Nonidet P-40 
5mM PMSF     150mM NaCl 
25mM Tris-Cl pH 7.5    1% Triton-X 100 
0.5% deoxycholate 
Make up to 1L prior to use. 
